<SEC-DOCUMENT>0001104659-25-075178.txt : 20250807
<SEC-HEADER>0001104659-25-075178.hdr.sgml : 20250807
<ACCEPTANCE-DATETIME>20250807160645
ACCESSION NUMBER:		0001104659-25-075178
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20250801
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250807
DATE AS OF CHANGE:		20250807

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			XCel Brands, Inc.
		CENTRAL INDEX KEY:			0001083220
		STANDARD INDUSTRIAL CLASSIFICATION:	PATENT OWNERS & LESSORS [6794]
		ORGANIZATION NAME:           	05 Real Estate & Construction
		EIN:				760307819
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37527
		FILM NUMBER:		251193944

	BUSINESS ADDRESS:	
		STREET 1:		1333 BROADWAY
		STREET 2:		10TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10018
		BUSINESS PHONE:		(347) 727-2474

	MAIL ADDRESS:	
		STREET 1:		1333 BROADWAY
		STREET 2:		10TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10018

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NETFABRIC HOLDINGS, INC
		DATE OF NAME CHANGE:	20050516

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HOUSTON OPERATING CO
		DATE OF NAME CHANGE:	19990402
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2522654d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:xelb="http://xcelbrands.com/20250801">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_035_xelb_xcelbrands.com_20250801 -->
<!-- Field: Set; Name: xdx; ID: xdx_046_20250801_20250801 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DEntityCentralIndexKey_0001083220 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-08-01" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-08-01" id="Fact000004" name="dei:EntityCentralIndexKey">0001083220</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="xelb-20250801.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-08-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001083220</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-08-01</xbrli:startDate>
        <xbrli:endDate>2025-08-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WASHINGTON, DC 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_904_edei--DocumentType_c20250801__20250801_zvsYYKHwhmw8"><ix:nonNumeric contextRef="AsOf2025-08-01" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15 (d)<br/>
of The Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of earliest event reported):
<span id="xdx_907_edei--DocumentPeriodEndDate_c20250801__20250801_z1W4GOVxSay7"><ix:nonNumeric contextRef="AsOf2025-08-01" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">August 1, 2025</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_902_edei--EntityRegistrantName_c20250801__20250801_zfTEpMHNDih8"><ix:nonNumeric contextRef="AsOf2025-08-01" id="Fact000011" name="dei:EntityRegistrantName">XCEL BRANDS, INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Exact name of registrant as specified in its
charter)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: center; width: 32%"><b><span id="xdx_904_edei--EntityIncorporationStateCountryCode_c20250801__20250801_zAKys79qvzJd"><ix:nonNumeric contextRef="AsOf2025-08-01" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></td>
    <td style="font-size: 10pt; text-align: center; width: 2%">&#160;</td>
    <td style="font-size: 10pt; text-align: center; width: 32%"><span style="font-size: 10pt"><b><span id="xdx_907_edei--EntityFileNumber_c20250801__20250801_zRZXWwONrr7"><ix:nonNumeric contextRef="AsOf2025-08-01" id="Fact000013" name="dei:EntityFileNumber">001-37527</ix:nonNumeric></span></b></span></td>
    <td style="font-size: 10pt; text-align: center; width: 2%">&#160;</td>
    <td style="font-size: 10pt; text-align: center; width: 32%"><span style="font-size: 10pt"><b><span id="xdx_90D_edei--EntityTaxIdentificationNumber_c20250801__20250801_zxN4q27H5tW2"><ix:nonNumeric contextRef="AsOf2025-08-01" id="Fact000014" name="dei:EntityTaxIdentificationNumber">76-0307819</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: center"><b>(State or Other Jurisdiction of <br/>
Incorporation)</b></td>
    <td style="text-align: center">&#160;</td>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt"><b>(Commission File<br/>
 Number)</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt"><b>(IRS Employer Identification<br/>
 No.)</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><b><span id="xdx_908_edei--EntityAddressAddressLine1_c20250801__20250801_zDLjKa8g2d22"><ix:nonNumeric contextRef="AsOf2025-08-01" id="Fact000015" name="dei:EntityAddressAddressLine1">550 Seventh Avenue</ix:nonNumeric></span>, <span id="xdx_904_edei--EntityAddressAddressLine2_c20250801__20250801_zUmvwztq9wNh"><ix:nonNumeric contextRef="AsOf2025-08-01" id="Fact000016" name="dei:EntityAddressAddressLine2">11th Floor</ix:nonNumeric></span>,<br/>
<span id="xdx_90F_edei--EntityAddressCityOrTown_c20250801__20250801_ztkhkDnVubah"><ix:nonNumeric contextRef="AsOf2025-08-01" id="Fact000017" name="dei:EntityAddressCityOrTown">New York</ix:nonNumeric></span>, <span id="xdx_90C_edei--EntityAddressStateOrProvince_c20250801__20250801_zF5O0ggL8BRh"><ix:nonNumeric contextRef="AsOf2025-08-01" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span></b></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_908_edei--EntityAddressPostalZipCode_c20250801__20250801_zlnO0IquNMq9"><ix:nonNumeric contextRef="AsOf2025-08-01" id="Fact000019" name="dei:EntityAddressPostalZipCode">10018</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><b>(Address of Principal Executive
    Offices)</b></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="font-size: 10pt; text-align: center"><b>(Zip Code)</b></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Registrant&#8217;s telephone number, including
area code (<span id="xdx_90E_edei--CityAreaCode_c20250801__20250801_zz2XaiZTHSV3"><ix:nonNumeric contextRef="AsOf2025-08-01" id="Fact000020" name="dei:CityAreaCode">347</ix:nonNumeric></span>) <span id="xdx_907_edei--LocalPhoneNumber_c20250801__20250801_zHtWjfxK1SO6"><ix:nonNumeric contextRef="AsOf2025-08-01" id="Fact000021" name="dei:LocalPhoneNumber">727-2474</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Not Applicable</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Former Name or Former Address, if Changed Since
Last Report)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<i>see</i>
General Instruction A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; width: 49px; font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_90C_edei--WrittenCommunications_c20250801__20250801_zz0MNHnx2FG4"><ix:nonNumeric contextRef="AsOf2025-08-01" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 5pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; width: 49px; font-size: 10pt; text-align: justify"><span style="font-family: Wingdings"><span id="xdx_90A_edei--SolicitingMaterial_c20250801__20250801_zgm4WnstC6Sl"><ix:nonNumeric contextRef="AsOf2025-08-01" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 5pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; width: 49px; font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_90D_edei--PreCommencementTenderOffer_c20250801__20250801_zicRNA4l8OBd"><ix:nonNumeric contextRef="AsOf2025-08-01" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 5pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; width: 49px; font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_90B_edei--PreCommencementIssuerTenderOffer_c20250801__20250801_zuoqhsYWxxQa"><ix:nonNumeric contextRef="AsOf2025-08-01" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">Emerging growth company <span style="font-family: Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_906_edei--EntityEmergingGrowthCompany_c20250801__20250801_zwU5on4XTBHb"><ix:nonNumeric contextRef="AsOf2025-08-01" format="ixt:booleanfalse" id="Fact000026" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Times New Roman, Times, Serif"><span style="font-family: Wingdings">&#168;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border: black 1pt solid; font-size: 10pt; text-align: center; width: 39%"><span style="font-size: 10pt">Title of each class</span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; font-size: 10pt; text-align: center; width: 23%"><span style="font-size: 10pt">Trading Symbol</span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; font-size: 10pt; text-align: center; width: 38%"><span style="font-size: 10pt">Name of each exchange on which<br/>
 registered</span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; font-size: 10pt; text-align: center"><span style="font-size: 10pt"><span id="xdx_908_edei--Security12bTitle_c20250801__20250801_z8hqJ1nhJms7"><ix:nonNumeric contextRef="AsOf2025-08-01" id="Fact000027" name="dei:Security12bTitle">Common Stock, par value $0.001 per share</ix:nonNumeric></span></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; font-size: 10pt; text-align: center"><span style="font-size: 10pt"><span id="xdx_90B_edei--TradingSymbol_c20250801__20250801_zGJAqVcEpq12"><ix:nonNumeric contextRef="AsOf2025-08-01" id="Fact000028" name="dei:TradingSymbol">XELB</ix:nonNumeric></span></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; font-size: 10pt; text-align: center"><span style="font-size: 10pt"><span id="xdx_905_edei--SecurityExchangeName_c20250801__20250801_zY95EUY9W0ck"><ix:nonNumeric contextRef="AsOf2025-08-01" format="ixt-sec:exchnameen" id="Fact000029" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric> </span>Capital Market</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: justify; width: 10%"><span style="font-size: 10pt"><b>Item 1.01.</b></span></td>
    <td style="font-size: 10pt; text-align: justify; width: 90%"><span style="font-size: 10pt"><b>Entry into a Material Definitive Agreement.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">On August 1, 2025, Xcel Brands,
Inc. (the &#8220;Registrant&#8221;) entered into a placement agency agreement (the &#8220;Placement Agency Agreement&#8221;) with Maxim
Group LLC </span>(the &#8220;Placement Agent&#8221;), as lead placement agent, relating to a best efforts public offering (the &#8220;Offering&#8221;)
of 2,181,818 shares (the &#8220;Shares&#8221;) of the Registrant&#8217;s common stock, par value $0.001 per share (&#8220;Common Stock&#8221;)
at a price to the public of $1.10 per Share. Robert W. D&#8217;Loren, Chairman and Chief Executive Officer of the Registrant (&#8220;D&#8217;Loren&#8221;)
purchased 124,200 Shares in the Offering, and Mark DiSanto, a Director of the Registrant (&#8220;DiSanto&#8221;) purchased 91,800 Shares
in the Offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Offering was made pursuant
to the Registrant&#8217;s registration statement on Form S-1, as amended (File No. 333-288495), previously filed with the Securities and
Exchange Commission (the &#8220;SEC&#8221;) on July 2, 2025, and declared effective on July 31, 2025, and a prospectus dated August 1,
2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The closing of the Offering
occurred on August 4, 2025. The aggregate net proceeds to the Registrant from the sale of the Securities and the Private Placement Shares
(defined below), after deducting the placement agent fees and other estimated offering expenses payable by the Registrant, are expected
to be approximately $2,000,000. The Registrant intends to use the net proceeds from the Offering for brand development and launch, working
capital and general corporate purposes. The Registrant issued a press release announcing the pricing of the Offering, which has been filed
as Exhibit 99.1 to this report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon closing of the Offering,
the Registrant issued the Placement Agent warrants (the &#8220;Placement Agent&#8217;s Warrants&#8221;) as compensation to purchase up
to 77,215 shares of Common Stock. The Placement Agent&#8217;s Warrants are exercisable at a per share exercise price of $1.10, in whole
or in part, during the four and one-half year period commencing 180 days from the commencement of sales of the Securities in the Offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Placement Agency Agreement
contains customary representations, warranties and covenants made by the Registrant. It also provides for customary indemnification by
each of the Registrant and the Placement Agent, severally and not jointly, for losses or damages arising out of or in connection with
the Offering, including for liabilities under the Securities Act of 1933, as amended (the &#8220;Act&#8221;), other obligations of the
parties and termination provisions. In addition, pursuant to the terms of the Placement Agency Agreement, each of the Registrant&#8217;s
directors and executive officers have entered into &#8220;lock-up&#8221; agreements with the Representative that generally prohibit, without
the prior written consent of the Representative and subject to certain exceptions, the sale, transfer or other disposition of securities
of the Registrant for a period of 90 days from the closing of the Offering. Further, pursuant to the terms of the Placement Agency Agreement,
the Registrant has agreed for a period of 90 days from the closing of the Offering, subject to certain exceptions, not to sell any shares
of its Common Stock, or any securities convertible into or exercisable or exchangeable into shares of its Common Stock, unless the Registrant
obtains prior written consent of the Placement Agent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing descriptions
of the Placement Agency Agreement and the Placement Agent&#8217;s Warrants do not purport to be complete and are qualified in their entirety
by reference to the copies of the Placement Agency Agreement and the form of Representative&#8217;s Warrant, which are filed herewith
as Exhibits 1.1 and 4.1, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The representations, warranties
and covenants contained in the Placement Agency Agreement were made only for purposes of such agreement and as of specific dates, were
solely for the benefit of the parties to the Placement Agency Agreement and may be subject to limitations agreed upon by the contracting
parties. Accordingly, the Placement Agency Agreement is incorporated herein by reference only to provide investors with information regarding
the terms of the Placement Agency Agreement, and not to provide investors with any other factual information regarding the Registrant
or its business, and should be read in conjunction with the disclosures in the Registrant&#8217;s periodic reports and other filings with
the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 1, 2025, the Registrant entered into a Securities Purchase
Agreement in favor of each purchaser (the &#8220;Securities Purchase Agreement&#8221;) to purchase the 2,181,818 Shares sold in the Offering.
The Securities Purchase Agreement contains customary representations, warranties and covenants made by the Registrant. The form of Securities
Purchase Agreement is filed herewith as Exhibit 10.1.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing description
of the Securities Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the Securities Purchase
Agreement, which is filed herewith as Exhibit 10.1.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 1, 2025, the Registrant
entered into Subscription Agreements (the &#8220;Subscription Agreements&#8221;) with D&#8217;Loren and DiSanto (collectively, the &#8220;Private
Placement Investors&#8221;) to purchase 82,159 and 60,883 shares, respectively, (the &#8220;Private Placement Shares&#8221;) at a price
of $1.38 per Private Placement Share. The purchase of the Private Placement Shares closed concurrently with the Offering. Upon closing
of the sale of the Private Placement Shares, the Registrant issued to the Placement Agent, as compensation, warrants to purchase up to
3,567 shares of Common Stock, which warrants were identical to the Placement Agent&#8217;s Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The foregoing descriptions of the Subscription
Agreements do not purport to be complete and are qualified in their entirety by reference to the copies of the Subscription Agreements,
which are filed herewith as Exhibits 10.2 and 10.3, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: justify; width: 10%"><span style="font-size: 10pt"><b>Item 3.02</b></span></td>
    <td style="font-size: 10pt; text-align: justify; width: 90%"><span style="font-size: 10pt"><b>Unregistered Sales of Equity Securities</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Private Placement Shares
referenced above were sold without registration under the Act, in reliance upon the exemptions from registration provided under Section
4(2) of the Act in reliance upon the exemptions from registration provided under Section 4(2) of the Act and Regulation D promulgated
under the Act (&#8220;Regulation D&#8221;). The Private Placement Investors represented in the Subscription Agreements, among other things,
that such Private Placement Investor was acquiring the Private Placement Shares for investment for the Private Placement Investor's account
and that the investor was an &#8220;accredited investor&#8221; within the meaning of Regulation D.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; width: 10%"><span style="font-size: 10pt"><b>Item 9.01</b></span></td>
    <td style="font-size: 10pt; width: 90%"><span style="font-size: 10pt"><b>Financial Statements and Exhibits. </b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
<tr style="vertical-align: top">
<td style="font-size: 10pt; width: 10%"><span style="font-size: 10pt">(d)</span></td>
<td style="font-size: 10pt; width: 90%"><span style="font-size: 10pt">Exhibits.</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; vertical-align: top; width: 5%"><a href="tm2522654d1_ex1-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">1.1</span></a></td>
    <td style="vertical-align: bottom; width: 94%"><a href="tm2522654d1_ex1-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Placement <span style="text-decoration: underline">Agency Agreement, dated as of August 1,
    2025, by and between Xcel Brands, Inc. and Maxim Group LLC.</span></span></a></td>
    </tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top"><a href="tm2522654d1_ex4-1.htm"><span style="font-size: 10pt">4.1</span></a></td>
    <td style="vertical-align: bottom"><a href="tm2522654d1_ex4-1.htm"><span style="font-size: 10pt">Form of Placement Agent&#8217;s Warrants.</span></a></td>
    </tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top"><a href="tm2522654d1_ex10-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">10.1</span></a></td>
    <td style="vertical-align: bottom"><a href="tm2522654d1_ex10-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt"><span style="text-decoration: underline">Form of Securities Purchase Agreement, by and between Xcel Brands,
    Inc. and the purchasers identified on the signature pages thereto</span></span></a></td>
    </tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top"><a href="tm2522654d1_ex10-2.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">10.2</span></a></td>
    <td style="vertical-align: bottom"><a href="tm2522654d1_ex10-2.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt"><span style="text-decoration: underline">Subscription Agreement, dated as of August 1, 2025, by and between
    Xcel Brands, Inc. and Robert W. D&#8217;Loren</span></span></a></td>
    </tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top"><a href="tm2522654d1_ex10-3.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">10.3</span></a></td>
    <td style="vertical-align: bottom"><a href="tm2522654d1_ex10-3.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt"><span style="text-decoration: underline">Subscription Agreement, dated as of August 1, 2025, by and between
    Xcel Brands, Inc. and Mark DiSanto</span></span></a></td>
    </tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top"><a href="tm2522654d1_ex99-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">99.1</span></a></td>
    <td style="vertical-align: bottom"><a href="tm2522654d1_ex99-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Press Release of Xcel Brands, Inc. dated August 1, 2025.</span></a></td>
    </tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-size: 10pt">104</span></td>
    <td><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within the inline XBRL document).</span></td>
    </tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">Date: August 7, 2025</span></td>
    <td colspan="2"><span style="font-size: 10pt"><b>XCEL BRANDS, INC.</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 50%">&#160;</td>
    <td style="width: 5%"><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; width: 45%"><span style="font-size: 10pt">/s/ James F. Haran</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Name:</span></td>
    <td><span style="font-size: 10pt">James F. Haran</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Title:</span></td>
    <td>Chief Financial Officer</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KgkAQhZ/Adxj2WvIHjPAyMYksQiK6XXKMJd2R2c3skXrLNiUaBoaZc745QviioI1qkeGyrko4Yde30iJU2CCjvqJzZNtdCm5WeFPGstR2Wn9gRo5BxywXkXT3yTkog3UK4SoIkyBOIIrTZAnHvfC+eka6UTVqq2QLUtdwZOpZoZX8mj+c5EiauteUdEY2inQK0SKc5TfEYRTDgQb5JL4bKMtMeP5UniiYHr1z5aNF/SUhb7FzcWam/+19AM7hSmI= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>tm2522654d1_ex1-1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: right; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: right; text-indent: 0.5in"><B>Exhibit 1.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: right; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0"><IMG SRC="tm2522654d1_ex1-1img001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: right; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>CONFIDENTIAL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">August&nbsp;1, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr.&nbsp;James F. Haran</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Financial Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Xcel Brands,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">550 Seventh Ave, 11th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, NY 10018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Mr.&nbsp;Haran,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify">This agreement (the &ldquo;<U>Agreement</U>&rdquo;)
constitutes the agreement between Xcel Brands,&nbsp;Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), and Maxim Group LLC
(&ldquo;<U>Maxim</U>&rdquo; or the &ldquo;<U>Lead Manager</U>&rdquo;), that Maxim shall serve as the exclusive lead placement agent for
the Company, on a &ldquo;reasonable best efforts&rdquo; basis (a &ldquo;<U>Placement</U>&rdquo;), in connection with the proposed offerings
of securities (the &ldquo;<U>Securities</U>&rdquo;) of the Company. The terms of such Placement and the Securities shall be mutually agreed
upon by the Company and the Lead Manager and, if a direct placement, the purchasers (each, a &ldquo;<U>Purchaser</U>&rdquo; and collectively,
the &ldquo;<U>Purchasers</U>&rdquo;) and nothing herein grants Maxim the power or authority to bind the Company or any Purchaser or creates
an obligation for the Company to issue any Securities or complete the Placement. This Agreement and the documents executed and delivered
by the Company and the Purchasers in connection with the Placement shall be collectively referred to herein as the &ldquo;<U>Transaction
Documents</U>.&rdquo; The date of the closing of the Placement shall be referred to herein as the &ldquo;<U>Closing Date</U>.&rdquo; The
Company expressly acknowledges and agrees that Maxim&rsquo;s obligations hereunder are on a reasonable best efforts basis only and that
the execution of this Agreement does not constitute a commitment by Maxim to purchase the Securities and does not ensure the successful
placement of the Securities or any portion thereof or the success of Maxim with respect to securing any other financing on behalf of the
Company. Maxim may retain other brokers or dealers to act as sub-agents or selected-dealers on its behalf in connection with the Placement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The sale of Securities to
any Purchaser will be evidenced by a purchase agreement (&ldquo;<U>Purchase Agreement</U>&rdquo;) between the Company and such Purchaser,
if required by the Purchaser, in a form reasonably satisfactory to the Company and Maxim. Prior to the signing of any Purchase Agreement,
officers of the Company with responsibility for financial affairs will be reasonably available to answer inquiries from prospective Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding anything herein
to the contrary, in the event that Maxim determines that any of the terms provided for hereunder shall not comply with a FINRA rule, including,
but not limited to, FINRA Rule&nbsp;5110, then the Company shall agree to amend this Agreement in writing upon the request of Maxim to
comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">300
Park Avenue, 16th Floor * New York, NY 10022 * (212) 895-3500 * (800) 724-0761 * fax (212) 895-3783 * www.maximgrp.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Xcel Brands,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">August&nbsp;1, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT>Page&nbsp;2</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>SECTION&nbsp;1.</U></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Compensation
and other Fees.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As compensation for the services
provided by Maxim hereunder, the Company agrees to pay to Maxim the fees set forth below with respect to the Placement:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.3in">(i)</TD><TD STYLE="text-align: justify">A cash fee (&ldquo;<U>Cash Fee</U>&rdquo;) payable immediately upon the closing of the Placement: (i)&nbsp;equal
to 8.0% of the gross proceeds to us from the sale of the Securities in the offering with respect to gross proceeds of the offering up
to $5,000,000, (ii)&nbsp;equal to 7.0% of the gross proceeds to us from the sale of the Securities in the offering with respect to gross
proceeds of the offering in excess of $5,000,000 but less than $10,000,000, (iii)&nbsp;equal to six percent (6.0%) of the gross proceeds
to us from the sale of the Securities in the offering with respect to gross proceeds of the offering equal to or greater than $10,000,000.
Notwithstanding the foregoing, the Cash Fee with respect to certain investors identified by the Company as listed on <U>Schedule I</U>
attached hereto (the &ldquo;<U>Company Identified Investors</U>&rdquo;), any member of management or a director of the Company (&ldquo;<U>Insiders</U>&rdquo;),
or Hilco Global or UTG Capital,&nbsp;Inc (&ldquo;<U>UTG</U>&rdquo;) shall be five percent (5.0%).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)</FONT></TD><TD STYLE="text-align: justify">Subject to compliance with FINRA Rule&nbsp;5110(f)(2)(D), the Company also agrees, in case of a Closing
of the Placement, to reimburse the Lead Manager for all reasonable and documented out-of-pocket expenses incurred, including the reasonable
fees, costs and disbursements of its legal counsel, in an amount not to exceed an aggregate of $100,000; <U>provided</U>, however, that
if the Placement is terminated, then such reimbursement shall not exceed an aggregate of $35,000. The Company will reimburse Lead Manager
directly upon the Closing of the Placement from the gross proceeds raised in the Placement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iii)</FONT></TD><TD STYLE="text-align: justify">Warrants (&ldquo;<U>Placement Agent Warrants</U>&rdquo;) to purchase: (i)&nbsp;4.0% of the aggregate number
of shares of common stock and/or Pre-Funded Warrants sold in this offering with respect to gross proceeds of the offering up to $5,000,000;
(ii)&nbsp;3.0% of the aggregate number of shares of common stock and/or Pre-Funded Warrants sold in this offering with respect to gross
proceeds of the offering in excess of $5,000,000 but less than $10,000,000 and (iii)&nbsp;0% with respect to gross proceeds equal to or
in excess of $10,000,000.. Such placement agent warrants will be non-exercisable for six (6)&nbsp;months after the Closing Date and will
expire five years after the commencement of sales of the offering. Notwithstanding the foregoing, the number of Placement Agent Warrants
issued with respect to Company Identified Investors shall be two and one-half percent (2.5%), and no Placement Agent Warrants shall be
issued in respect to any participation from Insiders of the Company and UTG.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>SECTION&nbsp;2.</U></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>RESERVED.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>SECTION&nbsp;3.</U></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>REPRESENTATIONS
AND WARRANTIES</U>. The Company makes to Maxim all of the representations and warranties which the Company makes to the Purchasers in
the Purchase Agreement, and in addition makes the following representation:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>FINRA
Affiliations</U></FONT>. There are no affiliations with any FINRA member firm among the Company&rsquo;s officers, directors or, to the
knowledge of the Company, any five percent (5%) or greater stockholder of the Company, except as set forth in the Company&rsquo;s public
filings under the Securities Exchange Act of 1934, as amended, with the Securities and Exchange Commission (the &ldquo;<U>SEC Filings</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>SECTION&nbsp;4.</U></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>REPRESENTATIONS
OF MAXIM</U>. Maxim represents and warrants that it is (i)&nbsp;a member in good standing of FINRA, (ii)&nbsp;registered as a broker/dealer
under the Securities Exchange Act of 1934 (the &ldquo;Exchange Act&rdquo;), and (iii)&nbsp;licensed as a broker/dealer under the laws
of the States applicable to the offers and sales of Securities by Maxim. Maxim will immediately notify the Company in writing of any change
in its status as such. Maxim covenants that it will use its reasonable best efforts to conduct the Transaction hereunder in compliance
with the provisions of this Agreement and the requirements of applicable law. Except as required by law or as contemplated by this agreement,
Maxim will keep confidential all material
nonpublic information, including information regarding the Transaction contemplated hereunder, provided to it by the Company or its affiliates
or advisors and use such information only for the purposes contemplated herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 8pt">Members FINRA &amp; SIPC</FONT></P><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 8pt">300 Park Avenue, 16th Floor * New York, NY 10022 * (212) 895-3500 * (800) 724-0761 * fax (212) 895-3783 * www.maximgrp.com</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Xcel Brands,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">August&nbsp;1, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page&nbsp;3</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>SECTION&nbsp;5.</U></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>INDEMNIFICATION</U>.
The Company agrees to the indemnification and other agreements set forth in the Indemnification Provisions (the &ldquo;<U>Indemnification</U>&rdquo;)
attached hereto as Addendum A, the provisions of which are incorporated herein by reference and shall survive the termination or expiration
of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>SECTION&nbsp;6.</U></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>ENGAGEMENT
TERM</U>. Maxim&rsquo;s engagement hereunder shall become effective on the date hereof and shall continue until the earlier of (a)&nbsp;the
Closing Date or (b)&nbsp;the date a party terminates the engagement according to the amendment to the letter agreement (the &ldquo;Amended
Letter Agreement&rdquo;) entered into between the Company and Maxim on April&nbsp;10, 2025 (such date, the &ldquo;Termination Date&rdquo;).
Notwithstanding anything to the contrary contained herein, the provisions concerning confidentiality, indemnification, contribution and
the Company&rsquo;s obligations to pay fees and reimburse expenses earned or due prior to the termination of the Agreement contained herein
and the Company&rsquo;s obligations contained in the Indemnification Provisions will survive any expiration or termination of this Agreement.
Maxim agrees not to use any confidential information concerning the Company provided to Maxim by the Company for any purposes other than
those contemplated under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>SECTION&nbsp;7.</U></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>TAIL
FEE</U>. Upon a Closing, or if the Engagement Period ends prior to Closing (other than a termination for &ldquo;Cause&rdquo;), then if
within twelve (12) months following such time, the Company completes any financing of equity, equity-linked, convertible or debt or other
capital raising activity with, or receives any proceeds from, any of the investors contacted or introduced by Maxim during the Engagement
Period (the &ldquo;Tail List&rdquo;), then the Company will pay Maxim upon the closing of such financing or receipt of such proceeds the
compensation equivalent to that set forth in Section&nbsp;1 herein. Upon written request from the Company following the Closing of an
Offering or termination of the Engagement Period, Maxim will provide the Tail List to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>SECTION&nbsp;8.</U></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>LEAD
MANAGER INFORMATION.</U> The Company agrees that any information or advice rendered by Maxim in connection with this engagement is for
the confidential use of the Company only in their evaluation of the Placement and, except as otherwise required by law, the Company will
not disclose or otherwise refer to the advice or information in any manner without Maxim&rsquo;s prior written consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>SECTION&nbsp;9.</U></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>NO
FIDUCIARY RELATIONSHIP.</U> This Agreement does not create, and shall not be construed as creating, rights enforceable by any person or
entity not a party hereto, except those entitled hereto by virtue of the Indemnification Provisions hereof. The Company acknowledges and
agrees that Maxim is and shall not be construed to be a fiduciary of the Company and shall have no duties or liabilities to the equity
holders or the creditors of the Company or any other person by virtue of this Agreement or the retention of Maxim hereunder, all of which
are hereby expressly waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>SECTION&nbsp;10.</U></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>CLOSING.</U>
The obligations of Maxim and the closing of the sale of the Securities hereunder are subject to the accuracy, when made and on the Closing
Date, of the representations and warranties on the part of the Company and its Subsidiaries contained herein, to the accuracy of the statements
of the Company and its Subsidiaries made in any certificates pursuant to the provisions hereof, to the performance by the Company and
its Subsidiaries of their obligations hereunder, and to each of the following additional terms and conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(A)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;All
corporate proceedings and other legal matters incident to the authorization, form, execution, delivery and validity of each of this
Agreement, the Securities, and all other legal matters relating to this Agreement and the transactions contemplated hereby shall be
reasonably satisfactory in all material respects to Maxim, and the Company shall have furnished to such counsel all documents and
information that they may reasonably request to enable them to pass upon such matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 8pt">Members FINRA &amp; SIPC</FONT></P><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 8pt">300 Park Avenue, 16th Floor * New York, NY 10022 * (212) 895-3500 * (800) 724-0761 * fax (212) 895-3783 * www.maximgrp.com</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Xcel Brands,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">August&nbsp;1, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page&nbsp;4</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(B)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Maxim
shall have received from outside counsel to the Company such counsel&rsquo;s written opinion, addressed to Maxim and dated as of the Closing
Date, in form and substance reasonably satisfactory to Maxim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(C)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Neither
the Company nor any of its Subsidiaries (i)&nbsp;shall have sustained since the date of the latest audited financial statements of the
Company included in the SEC Filings, any loss or interference with its business from fire, explosion, flood, terrorist act or other calamity,
whether or not covered by insurance, or from any labor dispute or court or governmental action, order or decree, otherwise than as set
forth in or contemplated by the SEC Filings, and (ii)&nbsp;since such date there shall not have been any change in the capital stock or
long-term debt of the Company or any of its subsidiaries or any change, or any development involving a prospective change, in or affecting
the business, general affairs, management, financial position, stockholders&rsquo; equity, results of operations or prospects of the Company
and its subsidiaries, otherwise than as set forth in or contemplated by the SEC Filings, the effect of which, in any such case described
in clause (i)&nbsp;or (ii), is, in the judgment of Maxim, so material and adverse as to make it impracticable or inadvisable to proceed
with the sale or delivery of the Securities on the terms and in the manner contemplated by the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(D)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
common stock of the Company is registered under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(E)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;No
action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any governmental
agency or body which would, as of the Closing Date, prevent the issuance or sale of the Securities or materially and adversely affect
or potentially and adversely affect the business or operations of the Company; and no injunction, restraining order or order of any other
nature by any federal or state court of competent jurisdiction shall have been issued as of the Closing Date which would prevent the issuance
or sale of the Securities or materially and adversely affect or potentially and adversely affect the business or operations of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(F)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company shall have prepared and filed with the Commission a Current Report on Form&nbsp;8-K with respect to the Placement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(G)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company shall have entered into Purchase Agreements with each of the Purchasers and such agreements shall be in full force and effect
and shall contain representations and warranties of the Company as agreed between the Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(H)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Prior
to the Closing Date, the Company shall have furnished to Maxim such further information, certificates and documents as Maxim may reasonably
request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>SECTION&nbsp;11</U></FONT>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>GOVERNING
LAW.</U> This Agreement will be governed by, and construed in accordance with, the laws of the State of New York applicable to
agreements made and to be performed entirely in such State. This Agreement may not be assigned by either party without the prior
written consent of the other party. This Agreement shall be binding upon and inure to the benefit of the parties hereto, and their
respective successors and permitted assigns. Any right to trial by jury with respect to any dispute arising under this Agreement or
any transaction or conduct in connection herewith is waived. Any dispute arising under this Agreement may be brought into the courts
of the State of New York or into the Federal Court located in New York, New York and, by execution and delivery of this Agreement,
the Company hereby accepts for itself and in respect of its property, generally and unconditionally, the jurisdiction of aforesaid
courts. Each party hereto hereby irrevocably waives personal service of process and consents to process being served in any such
suit, action or proceeding by delivering a copy thereof via overnight delivery (with evidence of delivery) to such party at the
address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service
of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner
permitted by law. If either party shall commence an action or proceeding to enforce any provisions of a Transaction Document, then
the prevailing party in such action or proceeding shall be reimbursed by the other party for its attorney&rsquo;s fees and other
costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 8pt">Members FINRA &amp; SIPC</FONT></P><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 8pt">300 Park Avenue, 16th Floor * New York, NY 10022 * (212) 895-3500 * (800) 724-0761 * fax (212) 895-3783 * www.maximgrp.com</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Xcel Brands,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">August&nbsp;1, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page&nbsp;5</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>SECTION&nbsp;12</U></FONT>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>ENTIRE
AGREEMENT/MISCELLANEOUS</U>. This Agreement (including the attached Indemnification Provisions) embodies the entire agreement and understanding
between the parties hereto and supersedes all prior agreements and understandings relating to the subject matter hereof, other than that
certain engagement letter entered into between the Company and Maxim, dated April&nbsp;10, 2025. If any provision of this Agreement is
determined to be invalid or unenforceable in any respect, such determination will not affect such provision in any other respect or any
other provision of this Agreement, which will remain in full force and effect. This Agreement may not be amended or otherwise modified
or waived except by an instrument in writing signed by Maxim and the Company. The representations, warranties, agreements and covenants
contained herein shall survive the closing of the Placement and delivery and/or exercise of the Securities, as applicable. This Agreement
may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall
become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties
need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or a &ldquo;.pdf&rdquo; format
file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed)
with the same force and effect as if such facsimile signature page&nbsp;were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>SECTION&nbsp;13</U></FONT>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>CONFIDENTIALITY</U>.
Maxim (i)&nbsp;will keep the Confidential Information (as such term is defined below) confidential and will not (except as required by
applicable law or stock exchange requirement, regulation or legal process), without the Company&rsquo;s prior written consent, disclose
to any person any Confidential Information, and (ii)&nbsp;will not use any Confidential Information other than in connection with its
evaluation of the Transaction. Maxim further agrees to disclose the Confidential Information only to its Representatives who need to know
the Confidential Information for the purpose of evaluating the Transaction, and who are informed by Maxim of the confidential nature of
the Confidential Information. The term &ldquo;<U>Confidential Information</U>&rdquo; shall mean, all confidential, proprietary and non-public
information (whether written, oral or electronic communications) furnished by the Company to Maxim or its Representatives in connection
with Maxim&rsquo;s evaluation of the Transaction. The term &ldquo;<U>Confidential Information</U>&rdquo; will not, however, include information
which (i)&nbsp;is or becomes publicly available other than as a result of a disclosure by Maxim or its Representatives in violation of
this Agreement, (ii)&nbsp;is or becomes available to Maxim or any of its Representatives on a nonconfidential basis from a third-party,
(iii)&nbsp;is known to Maxim or any of its Representatives prior to disclosure by the Company or any of its Representatives, (iv)&nbsp;is
or has been independently developed by Maxim and/or the Representatives without use of any Confidential Information furnished to it by
the Company, or (v)&nbsp;is required to be disclosed pursuant to applicable legal or regulatory authority.. The term &ldquo;Representatives&rdquo;
shall mean a party's directors, board committees, officers, employees, financial advisors, attorneys and accountants. This provision shall
be in full force until the earlier of (a)&nbsp;the date that the Confidential Information ceases to be confidential and (b)&nbsp;two years
from the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 8pt">Members FINRA &amp; SIPC</FONT></P><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 8pt">300 Park Avenue, 16th Floor * New York, NY 10022 * (212) 895-3500 * (800) 724-0761 * fax (212) 895-3783 * www.maximgrp.com</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Xcel Brands,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">August&nbsp;1, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page&nbsp;6</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>SECTION&nbsp;14</U></FONT>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>NOTICES.</U>
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and
shall be deemed given and effective on the earliest of (a)&nbsp;the date of transmission, if such notice or communication is
delivered via facsimile at the facsimile number specified on the signature pages&nbsp;attached hereto prior to 6:30 p.m.&nbsp;(New
York City time) on a business day, (b)&nbsp;the next business day after the date of transmission, if such notice or communication is
delivered via facsimile at the facsimile number on the signature pages&nbsp;attached hereto on a day that is not a business day or
later than 6:30 p.m.&nbsp;(New York City time) on any business day, (c)&nbsp;the business day following the date of mailing, if sent
by U.S. nationally recognized overnight courier service, or (d)&nbsp;upon actual receipt by the party to whom such notice is
required to be given. The address for such notices and communications shall be as set forth on the signature pages&nbsp;hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>[Signature page&nbsp;follows]</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 8pt">Members FINRA &amp; SIPC</FONT></P><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 8pt">300 Park Avenue, 16th Floor * New York, NY 10022 * (212) 895-3500 * (800) 724-0761 * fax (212) 895-3783 * www.maximgrp.com</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Xcel Brands,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">August&nbsp;1, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page&nbsp;7</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are excited about this equity offering and look forward to working
with you. Please confirm that the foregoing correctly sets forth our agreement by signing and returning the enclosed copy of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase"><FONT STYLE="font-size: 10pt">Maxim
    Group LLC</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-size: 10pt">/s/ Ritesh M. Veera</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Ritesh M. Veera</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Co-Head of Investment Banking</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><U>Address for notice:</U></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">300 Park Avenue<BR> 16th Floor<BR>
    New York, NY 10022</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accepted and Agreed to as of the date first
written above:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>XCEL BRANDS,&nbsp;INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">/s/ James F. Haran</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%">Name:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 43%"> James F. Haran</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Chief Financial Officer</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">Address for notice:</P>

<P STYLE="margin: 0">Xcel Brands,&nbsp;Inc.</P>

<P STYLE="margin: 0">550 Seventh Ave, 11th Floor</P>

<P STYLE="margin: 0">New York, NY 10018</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 8pt">Members FINRA &amp; SIPC</FONT></P><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 8pt">300 Park Avenue, 16th Floor * New York, NY 10022 * (212) 895-3500 * (800) 724-0761 * fax (212) 895-3783 * www.maximgrp.com</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Xcel Brands,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">August&nbsp;1, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page&nbsp;8</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>ADDENDUM</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>INDEMNIFICATION PROVISIONS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with the engagement of Maxim
Group LLC (&ldquo;<U>Maxim</U>&rdquo;) by Xcel Brands,&nbsp;Inc. (the &ldquo;<U>Company</U>&rdquo;) pursuant to this Agreement, the
Company hereby agrees as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">To the extent permitted by law, the Company will indemnify Maxim and each of its affiliates, directors,
officers, employees and controlling persons (within the meaning of Section&nbsp;15 of the Securities Act of 1933, as amended, or Section&nbsp;20
of the Securities Exchange Act of 1934, as amended) against all losses, claims, damages, expenses and liabilities, as the same are incurred
(including the reasonable fees and expenses of counsel), relating to or arising out of its activities hereunder or pursuant to the Agreement,
except, with regard to Maxim, to the extent that any losses, claims, damages, expenses or liabilities (or actions in respect thereof)
are found in a final judgment (not subject to appeal) by a court of law to have resulted primarily and directly from Maxim&rsquo;s willful
misconduct, gross negligence, bad faith or intentional misconduct in performing the services described herein, as the case may be.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promptly after receipt by Maxim
of notice of any claim or the commencement of any action or proceeding with respect to which Maxim is entitled to indemnity hereunder,
Maxim will notify the Company in writing of such claim or of the commencement of such action or proceeding, and the Company will assume
the defense of such action or proceeding and will employ counsel reasonably satisfactory to Maxim and will pay the fees and expenses of
such counsel. Notwithstanding the preceding sentence, Maxim will be entitled to employ counsel separate from counsel for the Company and
from any other party in such action if counsel for Maxim reasonably determines that it would be inappropriate under the applicable rules&nbsp;of
professional responsibility for the same counsel to represent both the Company and Maxim. In such event, the reasonable fees and disbursements
of no more than one such separate counsel for all indemnified parties will be paid by the Company. The Company will have the exclusive
right to settle the claim or proceeding provided that the Company will not settle any such claim, action or proceeding without the prior
written consent of Maxim, which will not be unreasonably withheld, </FONT>unless such settlement (x)&nbsp;includes an unconditional release
of Maxim from all liability on claims that are the subject matter of such proceeding and (y)&nbsp;does not include any statement as to
or any admission of fault, culpability or a failure to act by or on behalf of Maxim<FONT STYLE="font-size: 10pt">.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify">The Company agrees to notify Maxim promptly of the assertion against it or any other person of any claim
or the commencement of any action or proceeding relating to a transaction contemplated by the Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">4.</TD><TD STYLE="text-align: justify">If for any reason the foregoing indemnity is unavailable to Maxim or insufficient to hold Maxim harmless,
then the Company shall contribute to the amount paid or payable by Maxim, as the case may be, as a result of such losses, claims, damages
or liabilities in such proportion as is appropriate to reflect not only the relative benefits received by the Company on the one hand,
and Maxim on the other, but also the relative fault of the Company on the one hand and Maxim on the other that resulted in such losses,
claims, damages or liabilities, as well as any relevant equitable considerations. The amounts paid or payable by a party in respect of
losses, claims, damages and liabilities referred to above shall be deemed to include any legal or other fees and expenses incurred in
defending any litigation, proceeding or other action or claim. Notwithstanding the provisions hereof, Maxim&rsquo;s share of the liability
hereunder shall not be in excess of the amount of fees actually received, or to be received, by&#8239;Maxim under the Agreement (excluding
any amounts received as reimbursement of expenses incurred by Maxim).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 8pt">Members FINRA &amp; SIPC</FONT></P><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 8pt">300 Park Avenue, 16th Floor * New York, NY 10022 * (212) 895-3500 * (800) 724-0761 * fax (212) 895-3783 * www.maximgrp.com</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Xcel Brands,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">August&nbsp;1, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page&nbsp;9</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">5.</TD><TD STYLE="text-align: justify">These Indemnification Provisions shall remain in full force and effect whether or not the transaction
contemplated by the Agreement is completed and shall survive the termination of the Agreement, and shall be in addition to any liability
that the Company might otherwise have to any indemnified party under the Agreement or otherwise.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase"><FONT STYLE="font-size: 10pt">Maxim Group LLC</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%">/s/ Ritesh M. Veera</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Ritesh M. Veera</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Co-Head of Investment Banking</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><U>Address for notice:</U></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">300 Park Avenue<BR> 16th Floor<BR> New York, NY 10022</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accepted and Agreed to as of the date first
written above:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>XCEL BRANDS,&nbsp;INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">/s/ James F. Haran</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%">Name:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 43%">James F. Haran</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Chief Financial Officer</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">Address for notice:</P>

<P STYLE="margin: 0">Xcel Brands,&nbsp;Inc.</P>

<P STYLE="margin: 0">550 Seventh Ave, 11th Floor</P>

<P STYLE="margin: 0">New York, NY 10018</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 8pt">Members FINRA &amp; SIPC</FONT></P><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 8pt">300 Park Avenue, 16th Floor * New York, NY 10022 * (212) 895-3500 * (800) 724-0761 * fax (212) 895-3783 * www.maximgrp.com</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Company Identified Investors</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2522654d1_ex1-1img001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD>As defined in that certain engagement letter entered into between the Company and Maxim, dated April 10, 2025</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 8pt">300 Park Avenue, 16th Floor * New York, NY 10022 * (212) 895-3500 * (800) 724-0761 * fax (212) 895-3783 * www.maximgrp.com</FONT></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>tm2522654d1_ex4-1.htm
<DESCRIPTION>EXHIBIT 4.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B>xcel
brands, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif">Warrant Shares: 80,791</TD>
    <TD STYLE="text-align: right; width: 50%; font: 10pt Times New Roman, Times, Serif">Initial Exercise Date: [___], 2025</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: left; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS COMMON STOCK PURCHASE WARRANT
(the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, Maxim Group LLC or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time and from
time to time from and after the 181<SUP>st</SUP> day (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) immediately following the date of
effectiveness of that certain registration statement on Form S-1 (File No. 333-288495) filed by the Company, in accordance with FINRA
Rule 5110(g)(1), and through and including the five year anniversary of the date of effectiveness of that certain registration statement
on Form S-1 (File No. 333-288495), which such date is July 31, 2030 (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to
subscribe for and purchase from Xcel Brands, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to 80,791 shares (as
subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price of one share of Common Stock
under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1</U>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Definitions</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement,
dated August 1, 2025, among the Company and the purchasers signatory thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2</U>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any
time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed
PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank
unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original
Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant
to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full,
in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which
the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the
total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing
the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise
within one (1) Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree
that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of
Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Exercise Price</U>. The exercise price per share of Common Stock under this Warrant shall be <B>$</B>1.10, subject to adjustment
hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Cashless Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus
contained therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in whole
or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant
Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in">(A) = as applicable:
(i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1)
both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant
to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation
NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading
Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading
Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Holder&rsquo;s execution of the applicable
Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered
within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day)
pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise
is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular
trading hours&rdquo; on such Trading Day;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in">(B) = the Exercise
Price of this Warrant, as adjusted hereunder; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.3in">(X) = the number
of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were
by means of a cash exercise rather than a cashless exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised.&nbsp;&nbsp;The Company
agrees not to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m. (New York City
time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the
Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed
or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization
or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)&nbsp;in
all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by
the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses
of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a
similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock
so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">d)</TD><TD STYLE="text-align: justify"><U>Mechanics of Exercise</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 2.25in; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted
by the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in
such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of
the Warrant Shares by Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a certificate,
registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which
the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is
the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery
of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the
delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of
the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares
with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment
of the aggregate Exercise Price (other than in the case of a cashless exercise) is received by the Warrant Share Delivery Date. If the
Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery
Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject
to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing
to $20 per Trading Day on the fifth (5th) Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share
Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent
that is a participant in the Fast Automated Securities Transfer Program (FAST program) so long as this Warrant remains outstanding and
exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number
of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of
the Notice of Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;
</FONT><U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request
of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new
Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall
in all other respects be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iii.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;
</FONT><U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant
to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise by notifying the Company
of such rescission at any time prior to the delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"> iv.&#8239;&#8239;&#8239; <U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">v.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;
</FONT><U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vi.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;
</FONT><U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer
tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the
Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder;
<U>provided</U>, <U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder,
this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and
the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.
The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository
Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of
the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vii.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;
</FONT><U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">e)</TD><TD STYLE="text-align: justify"><U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant,
and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that
after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s
Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution
Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes of
the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties
shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is
being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised
portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion
of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock
Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the
Holder or any of its Affiliates or Attribution Parties.&nbsp; Except as set forth in the preceding sentence, for purposes of this Section
2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance
with Section 13(d) of the Exchange Act and the Holder is solely responsible for any reports or schedules required to be filed in accordance
therewith. To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable
(in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this
Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be
the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together
with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial
Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a
determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and
the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of
Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent
periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a
more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.&nbsp;
Upon the written or oral request of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder
the number of shares of Common Stock then outstanding.&nbsp; In any case, the number of outstanding shares of Common Stock shall be determined
after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates
or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial
Ownership Limitation</U>&rdquo; shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect
to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase
or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in
no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares
of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any
increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to
the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with
the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended
Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such
limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3</U>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or
otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable
in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise
of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way
of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares
of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction
of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before
such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the
number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this
Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record
date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after
the effective date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Reserved</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time while this Warrant
is outstanding the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other
property pro rata to the record holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder
will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have
acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard
to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date
on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which
the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent
(or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to
such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-underline-style: double">d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="color: blue">&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT></FONT><U>Pro Rata Distributions</U>. Except in the case of a Fundamental Transaction to which Section 3(e) below is applicable
or to which a notice under Section 3(g)(ii) below applies, during such time as this Warrant is outstanding, if the Company shall declare
or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way
of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options
by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder's right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation). To the extent that this Warrant has not been partially or completely exercised at the
time of such Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder until the Holder
has exercised this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in
one or more related transactions effects any merger or consolidation of the Company into another Person (excluding a merger effected solely
to change the Company&rsquo;s name or a re-domestication), (ii) the Company (and all of its Subsidiaries, taken as a whole), directly
or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of
its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether
by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their
shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv)
the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization
of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for
other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock
or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off,
merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of
the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party
to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination)
(each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right
to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental
Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number
of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional
consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of
the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without
regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the
Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among
the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.
If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then
the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such
Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor
(the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant in accordance
with the provisions of this Section 3(e) pursuant to written agreements prior to such Fundamental Transaction and shall, at the option
of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument
substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock
of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this
Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise
price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares
of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital
stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation
of such Fundamental Transaction). Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and
be substituted (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant referring to the &ldquo;Company&rdquo;
shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations
of the Company under this Warrant with the same effect as if such Successor Entity had been named as the Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;
</FONT><U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share,
as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given
date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Notice to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;
</FONT><U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form)
on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any
sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into
other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email
address as it shall appear upon the Warrant Register of the Company, at least 10 calendar days prior to the applicable record or effective
date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution,
redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be
entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that the Company, in consultation with its legal counsel, determines that any notice provided
in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company
shall comply with (i) its disclosure obligations under Regulation FD and (ii) the applicable instructions to Form 8-K. The Holder shall
remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering
such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4</U>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Transferability</U>. This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable,
in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. <FONT STYLE="text-decoration-style: double">Notwithstanding anything herein
to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned
this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date
on which the Holder delivers an assignment form to the Company assigning this Warrant in full.</FONT> The Warrant, if properly assigned
in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued. This
Warrant may not be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put,
or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days
immediately following the date of effectiveness of that certain registration statement on Form S-1 (File No. 333-288495) filed by the
Company, except as provided in FINRA Rule 5110(g)(2).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office
of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose
(the &ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat
the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5</U>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be
required to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding
Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Authorized Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the
necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall
be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles
of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the
transactions contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers,
shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City
of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of
New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated
hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that
it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient
venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any
such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
other manner permitted by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant,
the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys&rsquo; fees
and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;
</FONT><U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered,
and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder
shall operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other
provision of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in
any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses
including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting
any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"> h) &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notices</U>. Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice of Exercise, shall be in writing and delivered personally, or e-mail, or sent by a nationally recognized overnight courier service, addressed to the Company, at 550 Seventh Ave., 11<SUP>th</SUP> Floor New York, NY 10018, Attention: James Haran, email address: jharan@xcelbrands.com, or such other facsimile number, email address or address as the Company may specify for such purposes by notice to the Holders. Any and all notices or other communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by facsimile or e-mail, or sent by a nationally recognized overnight courier service addressed to each Holder at the facsimile number, e-mail address or address of such Holder appearing on the books of the Company. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i) the time of transmission, if such notice or communication is delivered via facsimile at the facsimile number or via e-mail at the e-mail address set forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number or via e-mail at the e-mail address set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given. To the extent that the Company, in consultation with its legal counsel, determines that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall comply with (i) its disclosure obligations under Regulation FD and (ii) the applicable instructions to Form 8-K.</P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the
Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages,
will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby
shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted
assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and
shall be enforceable by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company
and the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and
valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision
shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">n)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be
deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 0; padding-left: 0"><FONT STYLE="font-size: 10pt; text-transform: uppercase"><B>xcel brands,
    Inc.</B></FONT> <FONT STYLE="font-size: 10pt">&nbsp; &nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; width: 50%; padding-left: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; width: 3%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 0; padding-left: 0; width: 47%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0; padding-left: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0; padding-left: 0"><FONT STYLE="font-size: 10pt">Name:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0; padding-left: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0; padding-left: 0"><FONT STYLE="font-size: 10pt">Title:</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 2.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 2.5in"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">To:&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;XCEL
BRANDS, INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1)&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2)&#8239;&#8239;&#8239;&#8239;Payment shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Wingdings">&#168;</FONT>&#8239;in
lawful money of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">  <FONT STYLE="font-family: Wingdings">&#168;</FONT>&#8239;if permitted the
cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise
this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in
subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3)&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: ____________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: ______________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: _________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: ____________________________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">ASSIGNMENT FORM</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0; padding-right: 0; padding-left: 0">Name:</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 0; padding-right: 0; padding-left: 0"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 0; padding-bottom: 0; padding-left: 0; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 0; padding-left: 0; text-align: justify; font-size: 10pt">(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 0; padding-bottom: 0; padding-left: 0; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 0; padding-left: 0; text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0; padding-right: 0; padding-left: 0; text-align: justify; font-size: 10pt">Address:</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 0; padding-right: 0; padding-left: 0; text-align: justify; font-size: 10pt"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0; padding-right: 0; padding-left: 0; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-bottom: 0; padding-right: 0; padding-left: 0; text-align: justify; font-size: 10pt">(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0; padding-right: 0; padding-left: 0; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-bottom: 0; padding-right: 0; padding-left: 0; text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0; padding-right: 0; padding-left: 0">Phone Number:</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 0; padding-right: 0; padding-left: 0"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-bottom: 0; padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0; padding-right: 0; padding-left: 0">Email
Address:</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 0; padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-bottom: 0; padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 0; padding-bottom: 0; padding-left: 0; text-align: justify; font-size: 10pt"><FONT STYLE="color: black">Dated: _______________ __, ______</FONT></TD>
    <TD STYLE="padding-right: 0; padding-bottom: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 0; padding-left: 0; text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 0; padding-bottom: 0; padding-left: 0; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 0; padding-left: 0; text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-bottom: 0; padding-left: 0; text-align: justify; font-size: 10pt; width: 15%"><FONT STYLE="color: black">Holder&rsquo;s Signature:&#8239;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 0; padding-bottom: 0; padding-left: 0; text-align: justify; font-size: 10pt; width: 34%">&nbsp;</TD>
    <TD STYLE="padding-right: 0; width: 2%; padding-bottom: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 0; padding-left: 0; text-align: justify; font-size: 10pt; width: 49%"><FONT STYLE="color: black">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 0; padding-bottom: 0; padding-left: 0; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 0; padding-left: 0; text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-bottom: 0; padding-left: 0; text-align: justify; font-size: 10pt"><FONT STYLE="color: black">Holder&rsquo;s
    Address:&#8239;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 0; padding-bottom: 0; padding-left: 0; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-bottom: 0; padding-left: 0; text-align: justify; font-size: 10pt"><FONT STYLE="color: black">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<!-- Field: Page; Sequence: 19; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>tm2522654d1_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Securities Purchase Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is dated as of August&nbsp;1, 2025 between Xcel Brands,&nbsp;Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
and each purchaser identified on the signature pages&nbsp;hereto (each, including its successors and assigns, a &ldquo;<U>Purchaser</U>&rdquo;
and collectively the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, subject to the terms
and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act (as defined below)
as to the Shares and the Pre-Funded Warrants, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and
not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE,&nbsp;IN CONSIDERATION
of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are
hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;I.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">DEFINITIONS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.1 <U>Definitions</U>. In
addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings set
forth in this Section&nbsp;1.1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Acquiring
Person</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;4.5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(j).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person as such terms are used in and construed under Rule&nbsp;405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally
are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section&nbsp;2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i)&nbsp;the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii)&nbsp;the Company&rsquo;s
obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event later than the second (2<SUP>nd</SUP></FONT>)
Trading Day following the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure
Time</U>&rdquo; means, (i)&nbsp;if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m.&nbsp;(New York City
time) and before midnight (New York City time) on any Trading Day, 9:01 a.m.&nbsp;(New York City time) on the Trading Day immediately
following the date hereof, unless otherwise instructed as to an earlier time by the Placement Agent, and (ii)&nbsp;if this Agreement is
signed between midnight (New York City time) and 9:00 a.m.&nbsp;(New York City time) on any Trading Day, no later than 9:01 a.m.&nbsp;(New
York City time) on the date hereof, unless otherwise instructed as to an earlier time by the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a)&nbsp;shares of Common Stock, options or other equity awards to employees, officers, consultants
or directors of the Company pursuant to any incentive, stock or option plan duly adopted for such purpose, by a majority of the non-employee
members of the Board of Directors or a majority of the members of a committee of non-employee directors established for such purpose for
services rendered to the Company, (b)&nbsp;securities upon the exercise or exchange of or conversion of any Securities issued hereunder,
and/or other securities exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date
of this Agreement, provided that such securities have not been amended since the date of this Agreement to increase the number of such
securities or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection with stock
splits or combinations or otherwise pursuant to the terms in effect on the date hereof), (c)&nbsp;Securities issued to a lender in connection
with the incurrence of indebtedness and Securities issuable upon exercise, exchange or conversion thereof, <U>provided</U>, <U>however</U>,
that such issued Securities will be subject to a 90-day lock-up in accordance with the terms of the Lock-up Agreement attached herein
under Exhibit&nbsp;A and (d)&nbsp;securities issued pursuant to mergers, acquisitions, business combinations, joint ventures or strategic
transactions approved by a majority of the disinterested directors of the Company, provided that any such issuance shall only be to a
Person (or to the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset
in a business synergistic with the business of the Company and shall provide to the Company additional benefits in addition to the investment
of funds, but shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital
or to an entity whose primary business is investing in securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(aa).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(p).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Lock-Up
Agreement</U>&rdquo; means the Lock-Up Agreement, dated as of the date hereof, by and among the Company and the directors and officers
of the Company, in the form of <U>Exhibit&nbsp;A</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section&nbsp;3.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(n).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per Share
Purchase Price</U>&rdquo; equals $1.10, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations
and other similar transactions of the Common Stock that occur after the date of this Agreement; provided that the purchase price per Pre-Funded
Warrant shall be the Per Share Purchase Price minus $0.001.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement
Agent</U>&rdquo; means Maxim Group LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded
Warrant</U>&rdquo; means, collectively, the Pre-Funded Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance
with Section&nbsp;2.2(a)&nbsp;hereof, which Pre-Funded Warrants shall be exercisable immediately upon issuance and shall expire in accordance
with the terms thereof, in the form of <U>Exhibit&nbsp;B</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Product</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(hh).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus</U>&rdquo;
means the final prospectus filed for the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus
Supplement</U>&rdquo; means the supplement to the Prospectus complying with Rule&nbsp;424(b)&nbsp;of the Securities Act that is filed
with the Commission and delivered by the Company to each Purchaser at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;4.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means the effective registration statement with Commission File No.&nbsp;333-288495 which registers the sale of the
Shares and Pre-Funded Warrants and Pre-Funded Warrant Shares to the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule&nbsp;144</U>&rdquo;
means Rule&nbsp;144 promulgated by the Commission pursuant to the Securities Act, as such Rule&nbsp;may be amended or interpreted from
time to time, or any similar rule&nbsp;or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule&nbsp;424</U>&rdquo;
means Rule&nbsp;424 promulgated by the Commission pursuant to the Securities Act, as such Rule&nbsp;may be amended or interpreted from
time to time, or any similar rule&nbsp;or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Reports</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities</U>&rdquo;
means the Shares, the Pre-Funded Warrants and the Pre-Funded Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule&nbsp;200 of Regulation SHO under the Exchange Act (but shall not
be deemed to include locating and/or borrowing shares of Common Stock).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for Shares and Warrants purchased hereunder as specified
below such Purchaser&rsquo;s name on the signature page&nbsp;of this Agreement and next to the heading &ldquo;Subscription Amount,&rdquo;
in United States dollars and in immediately available funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth on <U>in the SEC Reports</U>, and shall, where applicable, also include any direct or
indirect subsidiary of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, the Pink Open Market, OTCQB or the OTCQX (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Pre-Funded Warrants, all exhibits and schedules thereto and hereto and any other documents
or agreements executed in connection with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means Continental Stock Transfer&nbsp;&amp; Trust Company, the current transfer agent of the Company, with an address
at 1 State Street, 30th Floor, New York, New York 10004 and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>ARTICLE&nbsp;II.<BR>
</B></FONT>PURCHASE AND SALE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.1 <U>Closing</U>. On the
Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the execution and delivery
of this Agreement by the parties hereto, the Company agrees to sell, and each Purchaser, severally and not jointly, agrees to purchase,
(i)&nbsp;such number of Shares and/or (ii)&nbsp;a Pre-Funded Warrant to purchase such number of shares of Common Stock, in each case,
as set forth on such Purchaser&rsquo;s signature page&nbsp;hereto, for an aggregate total purchase price equal to the Subscription Amount
set forth on such Purchaser&rsquo;s signature page&nbsp;hereto. Each Purchaser&rsquo;s Subscription Amount as set forth on the signature
page&nbsp;hereto executed by such Purchaser shall be made available for &ldquo;Delivery Versus Payment&rdquo; settlement with the Company
or its designee. The Company shall deliver to each Purchaser its respective Shares and Pre-Funded Warrant as determined pursuant to Section&nbsp;2.2(a),
and the Company and each Purchaser shall deliver the other items set forth in Section&nbsp;2.2 deliverable at the Closing. Upon satisfaction
of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall take place remotely by electronic transfer of the
Closing documentation. Unless otherwise directed by the Placement Agent, settlement of the Shares shall occur via &ldquo;Delivery Versus
Payment&rdquo; (&ldquo;<U>DVP</U>&rdquo;) (i.e., on the Closing Date, the Company shall issue the Shares registered in the Purchasers&rsquo;
names and addresses and released by the Transfer Agent directly to the account(s)&nbsp;at the Placement Agent identified by each Purchaser;
upon receipt of such Shares, the Placement Agent shall promptly electronically deliver such Shares to the applicable Purchaser, and payment
therefor shall be made by the Placement Agent (or its clearing firm) by wire transfer to the Company). Notwithstanding the foregoing,
with respect to any Notice(s)&nbsp;of Exercise (as defined in the Pre-Funded Warrants) delivered on or prior to 12:00 p.m.&nbsp;(New York
City time) on the Closing Date, which may be delivered at any time after the time of execution of this Agreement, the Company agrees to
deliver the Pre-Funded Warrant Shares subject to such notice(s)&nbsp;by 4:00 p.m.&nbsp;(New York City time) on the Closing Date and the
Closing Date shall be the Warrant Share Delivery Date (as defined in the Pre-Funded Warrants) for purposes hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">2.2 <U>Deliveries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;On or prior
to the Closing Date (except as indicated below), the Company shall deliver or cause to be delivered to each Purchaser the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;this Agreement
duly executed by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;a legal
opinion of Blank Rome LLP, substantially in form and substance reasonably satisfactory to the Placement Agent;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;subject
to the last sentence of Section&nbsp;2.1, the Company shall have provided each Purchaser with the Company&rsquo;s wire instructions, on
Company letterhead;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv)&nbsp;subject
to the last sentence of Section&nbsp;2.1, a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent
to deliver on an expedited basis via The Depository Trust Company Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;)
a number of Shares equal to the number of Shares set forth on such Purchaser&rsquo;s signature page&nbsp;hereto;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(v)&nbsp;if, applicable,
a Pre-Funded Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to such Purchaser&rsquo;s
Subscription Amount divided by the Per Share Purchase Price (rounded down to the nearest whole Share) (such number the &ldquo;<U>Specified
Base Share Number</U>&rdquo;), <I>minus</I> the number of Shares required to be delivered pursuant to Section&nbsp;2.2(a)(iv), with an
exercise price equal to $0.001, subject to adjustment therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(vi)&nbsp;On the date
hereof, the Placement Agent shall have received from each of Marcum LLP and CBIZ CPAs P.C. a letter dated the date of its delivery, addressed
to the Placement Agent, in form and substance reasonably satisfactory to the Placement Agent and counsel to the Placement Agent, containing
statements and information of the type ordinarily included in accountant&rsquo;s &ldquo;comfort letters&rdquo; to underwriters, delivered
according to Statement of Auditing Standards No.&nbsp;72 (or any successor bulletin), with respect to the audited and unaudited financial
statements and certain financial information contained in the Registration Statement and the Prospectus. At the Closing Date, the Placement
Agent shall have received from each of Marcum LLP and CBIZ CPAs P.C., a letter dated such date, in form and substance reasonably satisfactory
to the Placement Agent and counsel to the Placement Agent, to the effect that they reaffirm the statements made in the letter furnished
by them pursuant to the preceding sentence and have conducted additional procedures with respect to certain financial figures included
in the Prospectus, except that the specified date referred to therein for the carrying out of procedures shall be no more than three business
days prior to the Closing Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(vii)&nbsp;At the
Closing Date, there shall be furnished to the Placement Agent a certificate, dated the date of its delivery, signed by each of the Chief
Executive Officer and the Chief Financial Officer of the Company, in their capacities as such, and not individually, in form and substance
reasonably satisfactory to the Placement Agent and counsel to the Placement Agent, certifying and confirming the satisfaction of the closing
conditions listed in Section&nbsp;2.3(b);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(viii)&nbsp;the duly
executed Lock-Up Agreements; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ix)&nbsp;the Prospectus
and Prospectus Supplement (which may be delivered in accordance with Rule&nbsp;172 under the Securities Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;On or prior
to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;this Agreement
duly executed by such Purchaser; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;such Purchaser&rsquo;s
Subscription Amount, which shall be made available for &ldquo;Delivery Versus Payment&rdquo; settlement with the Company or its designee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.3 <U>Closing Conditions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;The obligations
of the Company hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;the accuracy
in all material respects (or, to the extent representations or warranties are qualified by materiality, in all respects) on the Closing
Date of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein in which case they
shall be accurate in all material respects (or, to the extent representations or warranties are qualified by materiality, in all respects)
as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;all obligations,
covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;the delivery
by each Purchaser of the items set forth in Section&nbsp;2.2(b)&nbsp;of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;The respective
obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;the accuracy
in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in
all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless as of a
specific date therein in which case they shall be accurate in all material respects or, to the extent representations or warranties are
qualified by materiality or Material Adverse Effect, in all respects) as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;all obligations,
covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;the delivery
by the Company of the items set forth in Section&nbsp;2.2(a)&nbsp;of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv)&nbsp;there shall
have been no Material Adverse Effect with respect to the Company since the date hereof; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(v)&nbsp;from the
date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s principal
Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have
been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such service,
or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude
in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser,
makes it impracticable or inadvisable to purchase the Securities at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>ARTICLE&nbsp;III.<BR>
</B></FONT>REPRESENTATIONS AND WARRANTIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.1 <U>Representations and
Warranties of the Company</U>. Except as explicitly described in the SEC Reports, which descriptions shall be deemed a part hereof and
shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the applicable SEC Report, the
Company hereby makes the following representations and warranties to each Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Subsidiaries</U>.
All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly,
all of the capital stock or other equity interests of each Subsidiary which it owns, free and clear of any Liens, and all of the issued
and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive
and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries
or any of them in the Transaction Documents shall be disregarded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Organization
and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing
and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to
own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in
violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational
or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign
corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification
necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected
to result in: (i)&nbsp;a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii)&nbsp;a
material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company
and the Subsidiaries, taken as a whole, or (iii)&nbsp;a material adverse effect on the Company&rsquo;s ability to perform in any material
respect on a timely basis its obligations under any Transaction Document (any of (i), (ii)&nbsp;or (iii), a &ldquo;<U>Material Adverse
Effect</U>&rdquo;) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke,
limit or curtail such power and authority or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Authorization;
Enforcement</U>. The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation
by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company
and no further action is required by the Company, the Board of Directors, a committee of the Board of Directors or the Company&rsquo;s
stockholders in connection herewith or therewith, in each case, other than in connection with the Required Approvals and subject to any
stockholder approval that may be requested by the Nasdaq Stock Market LLC,. This Agreement and each other Transaction Document to which
it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms
hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with
its terms, except (i)&nbsp;as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, fraudulent
conveyance, fraudulent transfer, moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights generally,
(ii)&nbsp;as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii)&nbsp;insofar
as indemnification and contribution provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>No Conflicts</U>.
The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it is a party, the
issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do not and will not
(i)&nbsp;conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles of incorporation,
bylaws or other organizational or charter documents, or (ii)&nbsp;conflict with, or constitute a default (or an event that with notice
or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the
Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments, acceleration
or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing
a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property
or asset of the Company or any Subsidiary is bound or affected, or (iii)&nbsp;subject to the Required Approvals, conflict with or result
in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority
to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property
or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii)&nbsp;and (iii), such as could
not have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>Filings,
Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to,
or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection
with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i)&nbsp;the filings required pursuant
to Section&nbsp;4.4 of this Agreement, (ii)&nbsp;with respect to applicable federal and state securities laws and the rules&nbsp;and regulations
of the Financial Industry regulatory Authority,&nbsp;Inc., and (iii)&nbsp;application(s)&nbsp;to each applicable Trading Market for the
listing of the Shares and the Pre-Funded Warrant Shares for trading thereon in the time and manner required thereby (collectively, the
 &ldquo;<U>Required Approvals</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)&nbsp;<U>Issuance
of the Securities; Registration</U>. The Securities are duly authorized and, when issued and paid for in accordance with the applicable
Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company.
The Pre-Funded Warrant Shares, when issued in accordance with the terms of the Pre-Funded Warrants, will be validly issued, fully paid
and nonassessable, free and clear of all Liens imposed by the Company. The Company has prepared and filed the Registration Statement in
conformity with the requirements of the Securities Act, which became effective on July&nbsp;31, 2025, including the Prospectus, and such
amendments and supplements thereto as may have been required to the date of this Agreement. The Registration Statement is effective under
the Securities Act and no stop order preventing or suspending the effectiveness of the Registration Statement or suspending or preventing
the use of the Prospectus has been issued by the Commission and no proceedings for that purpose have been instituted or, to the knowledge
of the Company, are threatened by the Commission. At the time the Registration Statement and any amendments thereto became effective,
at the date of this Agreement and at the Closing Date, the Registration Statement and any amendments thereto conformed and will conform
in all material respects to the requirements of the Securities Act and did not and will not contain any untrue statement of a material
fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading (other
than information with respect to Maxim Group LLC, as to which the Company makes no representation); and the Prospectus and any amendments
or supplements thereto, at the time the Prospectus or any amendment or supplement thereto was issued and at the Closing Date, conformed
and will conform in all material respects to the requirements of the Securities Act and did not and will not contain an untrue statement
of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading (other than information with respect to Maxim Group LLC, as to which the Company makes no representation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g)&nbsp;<U>Capitalization</U>.
The capitalization of the Company as of March&nbsp;31, 2025, is as set forth in the SEC Reports. The Company has not issued any capital
stock since its most recently filed periodic report under the Exchange Act, other than pursuant to (i)&nbsp;the exercise of employee stock
options and granting of restricted stock units under the Company&rsquo;s stock option plans and (ii)&nbsp;the issuance of shares of Common
Stock to employees pursuant to the Company&rsquo;s employee stock purchase plans and pursuant to the conversion and/or exercise of Common
Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act or set forth in the Registration
Statement and the Prospectus. No Person has any right of first refusal, preemptive right, right of participation, or any similar right
to participate in the transactions contemplated by the Transaction Documents which right has not been waived or satisfied. There are no
outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities,
rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire,
any shares of Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which
the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents or capital
stock of any Subsidiary. The issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue shares of Common
Stock or other securities to any Person (other than the Purchasers). There are no outstanding securities or instruments of the Company
or any Subsidiary with any provision that adjusts the exercise, conversion, exchange or reset price of such security or instrument upon
an issuance of securities by the Company or any Subsidiary. There are no outstanding securities or instruments of the Company or any Subsidiary
that contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the
Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any
stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement. All of the outstanding
shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance
with all federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar
rights to subscribe for or purchase securities. There are no stockholders agreements, voting agreements or other similar agreements with
respect to the Company&rsquo;s capital stock to which the Company is a party or, to the knowledge of the Company, between or among any
of the Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h)&nbsp;<U>SEC
Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be
filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section&nbsp;13(a)&nbsp;or 15(d)&nbsp;thereof,
for the two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material)
(the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with the Prospectus
and the Prospectus Supplement, being collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) As of their respective dates
(except to the extent any such SEC Report was subsequently amended), the SEC Reports complied in all material respects with the requirements
of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of
a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading. The Company is an issuer subject to Rule&nbsp;144(i)&nbsp;under
the Securities Act, and is not currently a &ldquo;shell company&rdquo; and at least one year has passed since it filed &ldquo;Form&nbsp;10
Information&rdquo; with the Commission. The financial statements of the Company included in the SEC Reports comply in all material respects
with applicable accounting requirements and the rules&nbsp;and regulations of the Commission with respect thereto as in effect at the
time of filing. Such financial statements have been prepared in accordance with United States generally accepted accounting principles
applied on a consistent basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;), except as may be otherwise specified in such financial
statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly
present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof
and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial,
year-end audit adjustments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>Material
Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included within
the SEC Reports, except as set forth in the SEC Reports, (i)&nbsp;there has been no event, occurrence or development that has had or that
could reasonably be expected to result in a Material Adverse Effect, (ii)&nbsp;the Company has not incurred any liabilities (contingent
or otherwise) other than (A)&nbsp;trade payables and accrued expenses incurred in the ordinary course of business consistent with past
practice and (B)&nbsp;liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed
in filings made with the Commission, (iii)&nbsp;the Company has not altered its method of accounting, (iv)&nbsp;the Company has not declared
or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase
or redeem any shares of its capital stock and (v)&nbsp;the Company has not issued any equity securities to any officer, director or Affiliate,
except pursuant to existing Company stock option plans. The Company does not have pending before the Commission any request for confidential
treatment of information. Except for the issuance of the Securities contemplated by this Agreement, no event, liability, fact, circumstance,
occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries
or their respective businesses, prospects, properties, operations, assets or financial condition that would be required to be disclosed
by the Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed
at least one Trading Day prior to the date that this representation is made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j)&nbsp;<U>Litigation</U>.
There is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened
against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental
or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an &ldquo;<U>Action</U>&rdquo;)
which could reasonably be expected to have a Material Adverse Effect on the Company. Neither the Company nor any Subsidiary, nor to the
knowledge of the Company, any director or officer thereof, is or has been the subject of any Action involving a claim of violation of
or liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of
the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any current or former
director or officer of the Company. The Commission has not issued any stop order or other order suspending the effectiveness of any registration
statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(k)&nbsp;<U>Labor
Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company,
which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo; employees
is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither the Company
nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships
with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary, is, or is now expected
to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement
or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued
employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any
of the foregoing matters. To the knowledge of the Company, the Company and its Subsidiaries are in compliance in all material respects
with all U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices, terms and conditions
of employment and wages and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(l)&nbsp;<U>Compliance</U>.
Neither the Company nor any Subsidiary: (i)&nbsp;is in default under or in violation of (and no event has occurred that has not been waived
that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or
any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement
or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default
or violation has been waived), (ii)&nbsp;is in violation of any judgment, decree or order of any court, arbitrator or other governmental
authority or (iii)&nbsp;is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including
without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety,
product quality and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result
in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(m)&nbsp;<U>Environmental
Laws</U>. The Company and its Subsidiaries (i)&nbsp;are in compliance with all federal, state, local and foreign laws relating to pollution
or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata),
including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or
hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise relating to
the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as
all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits,
plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii)&nbsp;have received
all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses; and
(iii)&nbsp;are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii)&nbsp;and
(iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(n)&nbsp;<U>Regulatory
Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal,
state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except
where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material
Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification
of any Material Permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(o)&nbsp;<U>Title
to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good
and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each
case free and clear of all Liens, except for (i)&nbsp;Liens as do not materially affect the value of such property and do not materially
interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii)&nbsp;Liens for the payment
of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of which
is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries
are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance, except
where such failure could not reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(p)&nbsp;<U>Intellectual
Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications,
service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights
necessary or required for use in connection with their respective businesses as described in the SEC Reports and which the failure to
so have would reasonably be expected to result in a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;).
Other than as set forth in the SEC Reports, none of, and neither the Company nor any Subsidiary has received a notice (written or otherwise)
that any of, the Intellectual Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned,
within two (2)&nbsp;years from the date of this Agreement, except as could not have or reasonably be expected to have a Material Adverse
Effect. Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within
the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe
upon the rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge
of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of
the Intellectual Property Rights, except as could not have or reasonably be expected to have a Material Adverse Effect. The Company and
its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual
properties, except where failure to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(q)&nbsp;<U>Insurance</U>.
The Company and the Subsidiaries are insured by insurers it believes to be of recognized financial responsibility against such losses
and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including,
but not limited to, directors and officers insurance coverage. Neither the Company nor any Subsidiary has any reason to believe that it
will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar
insurers as may be necessary to continue its business without a significant increase in cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(r)&nbsp;<U>Transactions
With Affiliates and Employees</U>. None of the officers or directors of the Company or any Subsidiary and, to the knowledge of the Company,
none of the employees of the Company or any Subsidiary is presently a party to any transaction with the Company or any Subsidiary (other
than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing
of services to or by, providing for rental of real or personal property to or from, providing for the borrowing of money from or lending
of money to or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any
entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee, stockholder,
member or partner, in each case in excess of $120,000 other than for (i)&nbsp;payment of salary or consulting fees for services rendered,
(ii)&nbsp;reimbursement for expenses incurred on behalf of the Company and (iii)&nbsp;other employee benefits, including stock option
agreements under any stock option plan of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(s)&nbsp;<U>Sarbanes-Oxley;
Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance with any and all applicable requirements of the Sarbanes-Oxley
Act of 2002, as amended, that are effective as of the date hereof, and any and all applicable rules&nbsp;and regulations promulgated by
the Commission thereunder that are effective as of the date hereof and as of the Closing Date. The Company and the Subsidiaries maintain
a system of internal accounting controls with the goal of providing reasonable assurance that: (i)&nbsp;transactions are executed in accordance
with management&rsquo;s general or specific authorizations, (ii)&nbsp;transactions are recorded as necessary to permit preparation of
financial statements in conformity with GAAP and to maintain asset accountability, (iii)&nbsp;access to assets is permitted only in accordance
with management&rsquo;s general or specific authorization, and (iv)&nbsp;the recorded accountability for assets is compared with the existing
assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company and the Subsidiaries have
established disclosure controls and procedures (as defined in Exchange Act Rules&nbsp;13a-15(e)&nbsp;and 15d-15(e)) for the Company and
the Subsidiaries and designed such disclosure controls and procedures to ensure that information required to be disclosed by the Company
in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified
in the Commission&rsquo;s rules&nbsp;and forms. The Company&rsquo;s certifying officers have evaluated the effectiveness of the disclosure
controls and procedures of the Company and the Subsidiaries as of the end of the period covered by the most recently filed periodic report
under the Exchange Act (such date, the &ldquo;<U>Evaluation Date</U>&rdquo;). The Company presented in its most recently filed periodic
report under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures
based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over
financial reporting (as such term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or
is reasonably likely to materially affect, the internal control over financial reporting of the Company and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(t)&nbsp;<U>Certain
Fees</U>. Except for fees payable by the Company to the Placement Agent, no brokerage or finder&rsquo;s fees or commissions are or will
be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker,
bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no obligation
with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section&nbsp;that
may be due in connection with the transactions contemplated by the Transaction Documents, other than any obligations incurred directly
by a Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(u)&nbsp;<U>Investment
Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be
or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended. The Company
shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration under the
Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(v)&nbsp;<U>Registration
Rights</U>. Except as disclosed in the Registration Statement and the Prospectus, no Person has any right to cause the Company or any
Subsidiary to effect the registration under the Securities Act of any securities of the Company or any Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(w)&nbsp;<U>Listing
and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section&nbsp;12(b)&nbsp;or 12(g)&nbsp;of the Exchange Act,
and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating
such registration. The Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which the
Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements
of such Trading Market. The Common Stock is currently eligible for electronic transfer through the Depository Trust Company or another
established clearing corporation and the Company is current in payment of the fees to the Depository Trust Company (or such other established
clearing corporation) in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(x)&nbsp;<U>Application
of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable
any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar
anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the laws of its state
of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations
or exercising their rights under the Transaction Documents, including without limitation as a result of the Company&rsquo;s issuance of
the Securities and the Purchasers&rsquo; ownership of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(y)&nbsp;<U>Disclosure</U>.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms
that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information
that it believes constitutes or might constitute material, non-public information which is not otherwise disclosed in the Prospectus Supplement.
The Company understands and confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities
of the Company. The Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties with respect
to the transactions contemplated hereby other than those specifically set forth in Section&nbsp;3.2 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(z)&nbsp;<U>No Integrated
Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section&nbsp;3.2, neither the
Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales
of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be
integrated with prior offerings by the Company for purposes of any applicable shareholder approval provisions of any Trading Market on
which any of the securities of the Company are listed or designated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(aa) <U>[RESERVED]</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(bb) <U>Tax Status</U>.
Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect,
the Company and its Subsidiaries each (i)&nbsp;has made or filed all United States federal, state and local income and all foreign income
and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii)&nbsp;has paid all taxes
and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and
declarations and (iii)&nbsp;has set aside on its books provision reasonably adequate for the payment of all material taxes for periods
subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed
to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such
claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(cc) <U>Foreign
Corrupt Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other
person acting on behalf of the Company or any Subsidiary, has (i)&nbsp;directly or indirectly, used any funds for unlawful contributions,
gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii)&nbsp;made any unlawful payment
to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds,
(iii)&nbsp;failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf
of which the Company is aware) which is in violation of law, or (iv)&nbsp;violated in any material respect any provision of FCPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(dd) <U>Accountants</U>.
To the knowledge and belief of the Company, the Company&rsquo;s accounting firm (i)&nbsp;is a registered public accounting firm as required
by the Exchange Act and (ii)&nbsp;shall express its opinion with respect to the financial statements to be included in the Company&rsquo;s
Annual Report for the fiscal year ending December&nbsp;31, 2025 (or such other fiscal year end then applicable to the Company).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ee) <U>Acknowledgment
Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers is acting solely
in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby.
The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity)
with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their
respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely
incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions
contemplated hereby by the Company and its representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ff) <U>Acknowledgment
Regarding Purchaser&rsquo;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding (except
for Sections 3.2(f)&nbsp;and 4.14 hereof), it is understood and acknowledged by the Company that: (i)&nbsp;none of the Purchasers has
been asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities
of the Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the Securities for any specified
term; (ii)&nbsp;past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales
or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future private placement transactions, may negatively
impact the market price of the Company&rsquo;s publicly-traded securities; (iii)&nbsp;any Purchaser, and counter-parties in &ldquo;derivative&rdquo;
transactions to which any such Purchaser is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the
Common Stock, and (iv)&nbsp;each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party
in any &ldquo;derivative&rdquo; transaction. The Company further understands and acknowledges that (y)&nbsp;one or more Purchasers may
engage in hedging activities at various times during the period that the Securities are outstanding, including, without limitation, during
the periods that the value of the Pre-Funded Warrant Shares deliverable with respect to Securities are being determined, and (z)&nbsp;such
hedging activities (if any) could reduce the value of the existing stockholders&rsquo; equity interests in the Company at and after the
time that the hedging activities are being conducted. The Company acknowledges that such aforementioned hedging activities do not constitute
a breach of any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(gg) <U>Regulation
M Compliance</U>. The Company has not, and to its knowledge no one acting on its behalf has, (i)&nbsp;taken, directly or indirectly, any
action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the
sale or resale of any of the Securities, (ii)&nbsp;sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any
of the Securities, or (iii)&nbsp;paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities
of the Company, other than, in the case of clauses (ii)&nbsp;and (iii), compensation paid to the Placement Agent in connection with the
placement of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(hh)[INTENTIONALLY
OMITTED]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;<U>Stock
Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i)&nbsp;in accordance
with the terms of the Company&rsquo;s stock option plan and (ii)&nbsp;with an exercise price at least equal to the fair market value of
the Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under
the Company&rsquo;s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company
policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the
release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(jj) <U>Cybersecurity</U>.
Except as would not reasonably be expected to result in a Material Adverse Event, (i)(x)&nbsp;there has been no security breach or other
compromise of or relating to any of the Company&rsquo;s or any Subsidiary&rsquo;s information technology and computer systems, networks,
hardware, software, data (including the data of its respective customers, employees, suppliers, vendors and any third party data maintained
by or on behalf of it), equipment or technology (collectively, &ldquo;<U>IT Systems and Data</U>&rdquo;) and (y)&nbsp;other than as disclosed
in the SEC Reports, the Company and the Subsidiaries have not been notified of, and has no knowledge of any event or condition that would
reasonably be expected to result in, any security breach or other compromise to its IT Systems and Data which had or could reasonably
be expected to have a Material Adverse Effect; (ii)&nbsp;to the knowledge of the Company, the Company and the Subsidiaries are presently
in compliance with all applicable laws or statutes and all judgments, orders, rules&nbsp;and regulations of any court or arbitrator or
governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems
and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as
would not, individually or in the aggregate, have a Material Adverse Effect; (iii)&nbsp;the Company and the Subsidiaries have implemented
and maintained commercially reasonable safeguards to maintain and protect its material confidential information and the integrity, continuous
operation, redundancy and security of all IT Systems and Data; and (iv)&nbsp;the Company and the Subsidiaries have implemented backup
and disaster recovery technology consistent with industry standards and practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(kk) <U>Office of
Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director, officer, agent,
employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign
Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ll) <U>U.S. Real
Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the meaning of
Section&nbsp;897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(mm) <U>Bank Holding
Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956, as
amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;<U>Federal
Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent
(5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of the total equity of a bank
or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or
Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to
regulation by the Federal Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(nn) <U>Money Laundering</U>.
The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance in all material respects with
applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended,
applicable money laundering statutes and applicable rules&nbsp;and regulations thereunder (collectively, the &ldquo;<U>Money Laundering
Laws</U>&rdquo;), and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving
the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary,
threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(oo) <U>Other Covered
Persons</U>. Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered Person) that has been
or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(pp) <U>Notice of
Disqualification Events</U>. The Company will notify the Purchasers in writing, prior to the Closing Date of (i)&nbsp;any Disqualification
Event relating to any Issuer Covered Person and (ii)&nbsp;any event that would, with the passage of time, reasonably be expected to become
a Disqualification Event relating to any Issuer Covered Person, in each case of which it is aware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.2 <U>Representations and
Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the date
hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate
as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(a)&nbsp;<U>Organization;
Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company
or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise
to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such
Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership,
limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a
party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute
the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except: (i)&nbsp;as limited
by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors&rsquo; rights generally, (ii)&nbsp;as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii)&nbsp;insofar as indemnification and contribution provisions may be limited by
applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">(b)&nbsp;</FONT><U>Own
Account</U>. Such Purchaser is acquiring the Securities as principal for its own account and has no direct or indirect arrangement or
understandings with any other persons to distribute or regarding the distribution of such Securities. Such Purchaser is acquiring the
Securities hereunder in the ordinary course of its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(c)&nbsp;<U>Experience
of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience
in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities,
and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the
Securities and, at the present time, is able to afford a complete loss of such investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(d)&nbsp;<U>Access
to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits
and schedules thereto) and the SEC Reports and has been afforded, (i)&nbsp;the opportunity to ask such questions as it has deemed necessary
of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities
and the merits and risks of investing in the Securities all such questions, if any, have been answered to its satisfaction; (ii)&nbsp;access
to information about the Company and its financial condition, results of operations, business, properties, management and prospects sufficient
to enable it to evaluate its investment; and (iii)&nbsp;the opportunity to obtain such additional information that the Company possesses
or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment.
Such Purchaser acknowledges and agrees that neither the Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser
with any information or advice with respect to the Securities nor is such information or advice necessary or desired. Neither the Placement
Agent nor any Affiliate has made or makes any representation as to the Company or the quality of the Securities and the Placement Agent
and any Affiliate may have acquired non-public information with respect to the Company which such Purchaser agrees need not be provided
to it. In connection with the issuance of the Securities to such Purchaser, neither the Placement Agent nor any of its Affiliates has
acted as a financial advisor or fiduciary to such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(e)&nbsp;<U>Certain
Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has
any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or
sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser first received
a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material pricing terms
of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the
case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s
assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions
of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to the portion of assets managed by
the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other than to other Persons
party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers, directors, partners,
legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made
to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for
the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect
to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company acknowledges and agrees that the representations
contained in this Section&nbsp;3.2 shall not modify, amend or affect such Purchaser&rsquo;s right to rely on the Company&rsquo;s representations
and warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document or any other
document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transactions contemplated
hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty,
or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;IV.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">OTHER AGREEMENTS OF THE PARTIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">4.1 <U>Legends</U>. The Shares, Pre-Funded Warrants
and Warrants shall be issued free of legends.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.2 <U>Furnishing of Information</U>.
Until the earlier of the time that no Purchaser owns Securities, the Company covenants to use its best efforts to timely file (or obtain
extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date
hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.3 <U>Integration</U>. The
Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section&nbsp;2
of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would be integrated with the
offer or sale of the Securities for purposes of the rules&nbsp;and regulations of any Trading Market such that it would require shareholder
approval prior to the closing of such other transaction unless shareholder approval is obtained before the closing of such subsequent
transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.4 <U>Securities Laws Disclosure;
Publicity</U>. The Company shall (a)&nbsp;by the Disclosure Time, issue a press release disclosing the material terms of the transactions
contemplated hereby, and (b)&nbsp;file a Current Report on Form&nbsp;8-K, including the Transaction Documents as exhibits thereto, with
the Commission within the time required by the Exchange Act. From and after the issuance of such press release. The Company represents
to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers by the
Company or any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agents, including, without
limitation, the Placement Agent, in connection with the transactions contemplated by the Transaction Documents. In addition, effective
upon the issuance of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations under
any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors, employees,
Affiliates or agents, including, without limitation, the Placement Agent, on the one hand, and any of the Purchasers or any of their Affiliates
on the other hand, shall terminate and be of no further force or effect. The Company understands and confirms that each Purchaser shall
be relying on the foregoing covenant in effecting transactions in securities of the Company. The Company and each Purchaser shall consult
with each other in issuing any other press releases with respect to the transactions contemplated hereby, and neither the Company nor
any Purchaser shall issue any such press release nor otherwise make any such public statement without the prior consent of the Company,
with respect to any press release of any Purchaser, which consent shall not unreasonably be withheld or delayed, except if such disclosure
is required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement
or communication. Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name
of any Purchaser in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such
Purchaser, except (a)&nbsp;as required by federal securities law in connection with the filing of final Transaction Documents with the
Commission and (b)&nbsp;to the extent such disclosure is required by law or Trading Market regulations, in which case the Company shall
provide the Purchasers with prior notice of such disclosure permitted under this clause (b)&nbsp;and reasonably cooperate with such Purchaser
regarding such disclosure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.5 <U>Shareholder Rights
Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser is
an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill (including any distribution
under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser
could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents
or under any other agreement between the Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.6 <U>Non-Public Information</U>.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, which shall be
disclosed pursuant to Section&nbsp;4.4, the Company covenants and agrees that, unless requested by a Purchaser, neither it, nor any other
Person acting on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company
reasonably believes constitutes, material non-public information, unless prior thereto such Purchaser shall have consented in writing
to the receipt of such information and agreed in writing with the Company to keep such information confidential. The Company understands
and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To
the extent that the Company, any of its Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates
delivers any material, non-public information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants and
agrees that such Purchaser shall not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective
officers, directors, employees, Affiliates or agents, including, without limitation, the Placement Agent, or a duty to the Company, any
of its Subsidiaries or any of their respective officers, directors, employees, Affiliates or agents, including, without limitation, the
Placement Agent, not to trade on the basis of, such material, non-public information, provided that the Purchaser shall remain subject
to applicable law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public
information regarding the Company or any Subsidiaries, the Company shall simultaneously with the delivery of such notice file such notice
with the Commission pursuant to a Current Report on Form&nbsp;8-K. The Company understands and confirms that each Purchaser shall be relying
on the foregoing covenant in effecting transactions in securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.7 <U>Use of Proceeds</U>.
The Company shall use the net proceeds from the sale of the Securities hereunder in the manner set forth in the Prospectus, and shall
not use such proceeds: (a)&nbsp;for the satisfaction of any portion of the Company&rsquo;s debt (other than payment of trade payables
and accrued liabilities in the ordinary course of the Company&rsquo;s business and prior practices), (b)&nbsp;for the redemption of any
Common Stock or Common Stock Equivalents, (c)&nbsp;for the settlement of any outstanding litigation or (d)&nbsp;in violation of FCPA or
OFAC regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.8 <U>Indemnification of
Purchasers</U>. Subject to the provisions of this Section&nbsp;4.8, the Company will indemnify and hold each Purchaser and its directors,
officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person
holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning
of Section&nbsp;15 of the Securities Act and Section&nbsp;20 of the Exchange Act), and the directors, officers, shareholders, agents,
members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding
a lack of such title or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless from any
and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in
settlements, court costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or incur
as a result of or relating to (a)&nbsp;any breach of any of the representations, warranties, covenants or agreements made by the Company
in this Agreement or in the other Transaction Documents or (b)&nbsp;any action instituted against the Purchaser Parties in any capacity
(including a Purchaser Party&rsquo;s status as an investor), or any of them or their respective Affiliates, by the Company or any stockholder
of the Company who is not an Affiliate of such Purchaser Party, arising out of or relating to any of the transactions contemplated by
the Transaction Documents. For the avoidance of doubt, the indemnification provided herein is intended to, and shall also cover, direct
claims brought by the Company against the Purchaser Parties; provided, however, that such indemnification shall not cover any loss, claim,
damage or liability to the extent it is finally judicially determined to be attributable to any Purchaser Party&rsquo;s breach of any
of the representations, warranties, covenants or agreements made by such Purchaser Party in any Transaction Document or any conduct by
a Purchaser Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct. If any action shall
be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall
promptly notify the Company in writing, and, except with respect to direct claims brought by the Company, the Company shall have the right
to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party (Blank Rome LLP is acceptable
to the Purchasers). Any Purchaser Party shall have the right to employ separate counsel in any such action and participate in the defense
thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (i)&nbsp;the
employment thereof has been specifically authorized by the Company in writing, (ii)&nbsp;the Company has failed after a reasonable period
of time to assume such defense and to employ counsel or (iii)&nbsp;in such action there is, in the reasonable opinion of counsel to the
applicable Purchaser Party (which may be internal counsel), a material conflict on any material issue between the position of the Company
and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more
than one such separate counsel for all Purchasers. The Company will not be liable to any Purchaser Party under this Agreement for any
settlement by a Purchaser Party effected without the Company&rsquo;s prior written consent, which shall not be unreasonably withheld or
delayed. In addition, if any Purchaser Party takes actions to collect amounts due under any Transaction Documents or to enforce the provisions
of any Transaction Documents, then the Company shall pay the costs incurred by such Purchaser Party for such collection, enforcement or
action, including, but not limited to, attorneys&rsquo; fees and disbursements. The indemnification and other payment obligations required
by this Section&nbsp;4.8 shall be made by periodic payments of the amount thereof during the course of the investigation, defense, collection,
enforcement or action, as and when bills are reasonably incurred and received; provided, that if any Purchaser Party is finally judicially
determined not to be entitled to indemnification or payment under this Section&nbsp;4.8, such Purchaser Party shall promptly reimburse
the Company for any payments that are advanced under this sentence. The indemnity agreements contained herein shall be in addition to
any cause of action or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject
to pursuant to law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.9 <U>Reservation of Common
Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all times,
free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue the Shares pursuant
to this Agreement and Pre-Funded Warrant Shares pursuant to any exercise of the Pre-Funded Warrants. The Company shall reserve and keep
available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company
to issue the Pre-Funded Warrant Shares pursuant to any exercise of the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.10 <U>Listing of Common
Stock</U>. For as long as any Pre-Funded Warrants are outstanding and exercisable, the Company hereby agrees to use reasonable best efforts
to maintain the listing or quotation of the Common Stock on the Trading Market on which it is currently listed, and concurrently with
the Closing, the Company shall apply to list or quote all of the Shares and the Pre-Funded Warrant Shares on such Trading Market and promptly
secure the listing of all of the Shares and the Pre-Funded Warrant Shares on such Trading Market. The Company further agrees, if the Company
applies to have the Common Stock traded on any other Trading Market, it will then include in such application all of the Shares and the
Pre-Funded Warrant Shares, and will take such other action as is necessary to cause all of the Shares and the Pre-Funded Warrant Shares
to be listed or quoted on such other Trading Market as promptly as possible. The Company will then take all action reasonably necessary
to continue the listing and trading of its Common Stock on a Trading Market and will comply in all material respects with the Company&rsquo;s
reporting, filing and other obligations under the bylaws or rules&nbsp;of the Trading Market. For so long as the Company maintains a listing
or quotation of the Common Stock on a Trading Market, the Company agrees to maintain the eligibility of the Common Stock for electronic
transfer through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment
of fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.11 <U>Subsequent Equity
Sales</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;From the
date hereof until 90 days after the date hereof, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue
or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(b)&nbsp;</FONT>From
the date hereof until one (1)&nbsp;year after the Closing Date, the Company shall be prohibited from effecting or entering into an agreement
to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination of units
thereof) involving a Variable Rate Transaction. &ldquo;<U>Variable Rate Transaction</U>&rdquo; means a transaction in which the Company
(i)&nbsp;issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right
to receive additional shares of Common Stock either (A)&nbsp;at a conversion price, exercise price or exchange rate or other price that
is based upon, and/or varies with, the trading prices of or quotations for the shares of Common Stock at any time after the initial issuance
of such debt or equity securities or (B)&nbsp;with a conversion, exercise or exchange price that is subject to being reset at some future
date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly
related to the business of the Company or the market for the Common Stock or (ii)&nbsp;enters into, or effects a transaction under, any
agreement, including, but not limited to, an equity line of credit or an &ldquo;at-the-market offering&rdquo;, whereby the Company may
issue securities at a future determined price regardless of whether shares pursuant to such agreement have actually been issued and regardless
of whether such agreement is subsequently canceled. Any Purchaser shall be entitled to obtain injunctive relief against the Company to
preclude any such issuance, which remedy shall be in addition to any right to collect damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(c)&nbsp;Notwithstanding
the foregoing, this Section&nbsp;4.11 shall not apply in respect of an Exempt </FONT>Issuance, except that no Variable Rate Transaction
shall be an Exempt Issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.12 <U>Equal Treatment of
Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid to any Person to amend
or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration is also offered to
all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate right granted to each
Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as a class
and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition or voting
of Securities or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.13 <U>Certain Transactions
and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it nor any Affiliate
acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short Sales of any of the
Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at such time that the transactions
contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section&nbsp;4.4. Each
Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated by this
Agreement are publicly disclosed by the Company pursuant to the initial press release as described in Section&nbsp;4.4, such Purchaser
will maintain the confidentiality of the existence and terms of this transaction (other than as disclosed to its legal and other representatives).
Notwithstanding the foregoing and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges
and agrees that (i)&nbsp;no Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions
in any securities of the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant
to the initial press release as described in Section&nbsp;4.4, (ii)&nbsp;no Purchaser shall be restricted or prohibited from effecting
any transactions in any securities of the Company in accordance with applicable securities laws from and after the time that the transactions
contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section&nbsp;4.4 and
(iii)&nbsp;no Purchaser shall have any duty of confidentiality or duty not to trade in the securities of the Company to the Company, any
of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agent, including, without limitation, the
Placement Agent, after the issuance of the initial press release as described in Section&nbsp;4.4. Notwithstanding the foregoing, in the
case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s
assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions
of such Purchaser&rsquo;s assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio
manager that made the investment decision to purchase the Securities covered by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.14 <U>Exercise Procedures</U>.
The form of Notice of Exercise included in the Pre-Funded Warrants set forth the totality of the procedures required of the Purchasers
in order to exercise such Pre-Funded Warrants, as applicable. No additional legal opinion, other information or instructions shall be
required of the Purchasers to exercise such Pre-Funded Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise
shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required
in order to exercise such Pre-Funded Warrants. The Company shall honor exercises of such Pre-Funded Warrants and shall deliver the Pre-Funded
Warrant Shares, as applicable, in accordance with the terms, conditions and time periods set forth in the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.15 <U>Lock-Up Agreements</U>.
The Company shall not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements except to extend the term of the
lock-up period and shall enforce the provisions of each Lock-Up Agreement in accordance with its terms. If any party to a Lock-Up Agreement
breaches any provision of a Lock-Up Agreement, the Company shall promptly use its best efforts to seek specific performance of the terms
of such Lock-Up Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>ARTICLE&nbsp;V.<BR>
</B></FONT>MISCELLANEOUS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">5.1
<U>Termination</U>. This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without
any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the
Closing has not been consummated on or before the fifth (5<SUP>th</SUP></FONT>) Trading Day following the date hereof; <U>provided</U>,
<U>however</U>, that no such termination will affect the right of any party to sue for any breach by any other party (or parties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.2 <U>Fees and Expenses</U>.
Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses of its advisers,
counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation,
execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without limitation, any
fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice delivered by a Purchaser),
stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.3 <U>Entire Agreement</U>.
The Transaction Documents, together with the exhibits and schedules thereto, the Prospectus and the Prospectus Supplement, contain the
entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings,
oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">5.4
<U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing
and shall be deemed given and effective on the earliest of: (a)&nbsp;the time of transmission, if such notice or communication is delivered
via email attachment at the email address as set forth on the signature pages&nbsp;attached hereto at or prior to 5:30 p.m.&nbsp;(New
York City time) on a Trading Day, (b)&nbsp;the next Trading Day after the time of transmission, if such notice or communication is delivered
via email attachment at the email address as set forth on the signature pages&nbsp;attached hereto on a day that is not a Trading Day
or later than 5:30 p.m.&nbsp;(New York City time) on any Trading Day, (c)&nbsp;the second (2<SUP>nd</SUP></FONT>) Trading Day following
the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d)&nbsp;upon actual receipt by the party to whom
such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages&nbsp;attached
hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.5 <U>Amendments; Waivers</U>.
No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of
an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares based on the initial Subscription
Amounts hereunder (or, prior to the Closing, the Company and each Purchaser) or, in the case of a waiver, by the party against whom enforcement
of any such waived provision is sought, provided that if any amendment, modification or waiver disproportionately and adversely impacts
a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser (or group of Purchasers) shall also be
required. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing
waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall
any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right. Any proposed amendment
or waiver that disproportionately, materially and adversely affects the rights and obligations of any Purchaser relative to the comparable
rights and obligations of the other Purchasers shall require the prior written consent of such adversely affected Purchaser. Any amendment
effected in accordance with this Section&nbsp;5.5 shall be binding upon each Purchaser and holder of Securities and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.6 <U>Headings</U>. The headings
herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions
hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.7 <U>Successors and Assigns</U>.
This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company may
not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other than by merger).
Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or transfers any Securities,
provided that such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions of the Transaction
Documents that apply to the &ldquo;Purchasers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.8 <U>No Third-Party Beneficiaries</U>.
The Placement Agent shall be a third party beneficiary of the representations and warranties of the Company in Section&nbsp;3.1 and the
representations and warranties of the Purchasers in Section&nbsp;3.2. This Agreement is intended for the benefit of the parties hereto
and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any
other Person, except as otherwise set forth in Section&nbsp;4.8 and this Section&nbsp;5.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.9 <U>Governing Law</U>.
All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed by
and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates,
directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts
sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting
in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction
contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably
waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such
court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives
personal service of process and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this
Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action
or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under Section&nbsp;4.8,
the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo;
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.10 <U>Survival</U>. The
representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.11 <U>Execution</U>. This
Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that
the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery of a &ldquo;.pdf&rdquo;
format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature
is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page&nbsp;were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.12 <U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.13 <U>Rescission and Withdrawal
Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any of the other Transaction
Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does not
timely perform its related obligations within the periods therein provided, then such Purchaser may rescind or withdraw, in its sole discretion
from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part without prejudice to
its future actions and rights; <U>provided</U>, <U>however</U>, that in the case of a rescission of an exercise of a Pre-Funded Warrant
or Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded exercise notice
concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and the restoration
of such Purchaser&rsquo;s right to acquire such shares pursuant to such Purchaser&rsquo;s Pre-Funded Warrant or Warrant (including, issuance
of a replacement warrant certificate evidencing such restored right).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.14 <U>Replacement of Securities</U>.
If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall issue or cause to
be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of and substitution therefor,
a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction.
The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs (including
customary indemnity) associated with the issuance of such replacement Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.15 <U>Remedies</U>. In addition
to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers and
the Company may be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may not be
adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby agree
to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.16 <U>Payment Set Aside</U>.
To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser enforces
or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are
subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded,
repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without limitation, any
bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation
or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not
been made or such enforcement or setoff had not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.17 <U>Independent Nature
of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document are several and not
joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance
of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document,
and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently
protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction
Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose.
Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. For
reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to communicate with the Company through
Pryor Cashman LLP. Pryor Cashman LLP does not represent any of the Purchasers and only represents the Placement Agent. The Company has
elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not because it
was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that each provision contained in this
Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the Company and the Purchasers
collectively and not between and among the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.18 <U>Saturdays, Sundays,
Holidays,&nbsp;etc.</U> If the last or appointed day for the taking of any action or the expiration of any right required or granted herein
shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.19 <U>Construction</U>.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents
and, therefore, the normal rule&nbsp;of construction to the effect that any ambiguities are to be resolved against the drafting party
shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference
to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits,
stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.20 <B><U>WAIVER OF JURY
TRIAL</U>. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY
AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,&nbsp;IRREVOCABLY AND EXPRESSLY
WAIVES FOREVER TRIAL BY JURY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Pages&nbsp;Follow)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first
indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
<TD COLSPAN="2" STYLE="padding-bottom: 1.75pt"><B>XCEL BRANDS,&nbsp;INC.</B> <FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></TD>
<TD STYLE="padding-bottom: 1.75pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
<TD COLSPAN="2" STYLE="padding-bottom: 1.75pt">&nbsp;</TD>
<TD STYLE="padding-bottom: 1.75pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
<TD STYLE="width: 5%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
<TD STYLE="border-bottom: Black 1pt solid; width: 45%">&nbsp;</TD>
<TD STYLE="width: 50%; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
<TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
<TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;James Haran</FONT></TD>
<TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
<TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
<TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;Chief Financial Officer</FONT></TD>
<TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Notice:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">550 Seventh Avenue, 11<SUP>th</SUP> Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">E-Mail:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With a copy to (which shall not constitute notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Blank Rome LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1271 Avenue of the Americas</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10020<BR>
E-mail: brad.shiffman@blankrome.com&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: Brad L. Shiffman,&nbsp;Esq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Form&nbsp;of Lock-up Agreement</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Form&nbsp;of Pre-Funded Warrant</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>5
<FILENAME>tm2522654d1_ex10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; margin: 0"><FONT STYLE="font-size: 10pt"><B>Exhibit 10.2</B></FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">SUBSCRIPTION AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: justify; width: 50%"><FONT STYLE="font-size: 10pt">August
                                            1, 2025</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Xcel Brands,&nbsp;Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">550 Seventh Ave, 11<SUP>th</SUP> Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">New York, New York 10018</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">Ladies and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
undersigned hereby tenders this subscription and applies for the purchase of 82,159 shares of Common Stock (the &ldquo;Shares&rdquo;)
of Xcel Brands,&nbsp;Inc. (the &ldquo;Company&rdquo;) for an aggregate purchase price of $113,380.48. On or prior to 9:30 a.m.&nbsp;on
Monday, August&nbsp;4, 2025 the undersigned will deliver to the Company, via wire transfer of same day funds in accordance with instructions
by the Company in the full amount of the purchase price for the Shares which the undersigned is hereby subscribing for pursuant hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
order to induce the Company to accept this subscription, the undersigned hereby represents and warrants to, and covenants with, the Company
as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
undersigned has such knowledge and expertise in financial and business matters that the undersigned is capable of evaluating the merits
and risks involved in an investment in the Shares and the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
undersigned understands that the Company has determined that the exemption from the registration provisions of the Securities Act of
1933, as amended (the &ldquo;Act&rdquo;), which is based upon non-public offerings is applicable to the offer and sale of the Shares,
based, in part, upon the representations, warranties and agreements made by the undersigned herein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
undersigned understands that: (A)&nbsp;the shares have not been registered under the Act or the securities laws of any state, based upon
an exemption from such registration requirements for non-public offerings pursuant to Regulation D under the Act; (B)&nbsp;the Shares
are and will be &ldquo;restricted securities&rdquo;, as said term is defined in Rule&nbsp;144 of the Rules&nbsp;and Regulations promulgated
under the Act; (C)&nbsp;the Shares may not be sold or otherwise transferred unless they have been first registered under the Act and
all applicable state securities laws, or unless exemptions from such registration provisions are available with respect to said resale
or transfer; (D)&nbsp;the Company is under no obligation to register the Shares under the Act or any state securities laws, or to take
any action to make any exemption from any such registration provisions available; (E)&nbsp;the certificates for Shares will bear a legend
to the effect that the transfer of the securities represented thereby is subject to the provisions hereof; and (F)&nbsp;stop transfer
instructions will be placed with the transfer agent for the Common Stock;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(iv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
undersigned is acquiring the Shares solely for the account of the undersigned, for investment purposes only, and not with a view towards
the resale or distribution thereof;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(v)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;The
undersigned will not sell or otherwise transfer any of the Shares or any interest therein, unless and until: (A)&nbsp;said Shares shall
have first been registered under the Act and all applicable state securities laws; or (B)&nbsp;the undersigned shall have first delivered
to the Company a written opinion of counsel (which counsel and opinion (in form and substance) shall be satisfactory to the Company),
to the effect that the proposed sale or transfer is exempt from the registration provisions of the Act and all applicable state securities
laws;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(vi)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
undersigned has determined that the Shares are a suitable investment for the undersigned and that undersigned has the financial ability
to bear the economic risk of the undersigned&rsquo;s investment in the Company, has no need for liquidity with respect to such investment,
and has adequate means for providing for his or its current needs and contingencies;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(vii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
undersigned has full power and authority to execute and deliver this Subscription Agreement and to perform the obligations of the undersigned
hereunder, and each such agreement is a legally binding obligation of the undersigned in accordance with its terms;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(viii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
undersigned is an &ldquo;accredited investor,&rdquo; as such term is defined in Regulation D of the Rules&nbsp;and Regulations promulgated
under the Act;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(ix)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;The
address set forth below is the undersigned&rsquo;s true and correct residence, and the undersigned has no present intention of becoming
a resident of any other state or jurisdiction;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(x)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
undersigned does not have any contract, undertaking, agreement or arrangement with any person to sell, transfer or grant participations
to such person or to any third person, with respect to any of the Shares for which the undersigned is subscribing;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(xi)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;The
undersigned understands that an investment in the Shares is a speculative investment which involves a high degree of risk of loss of
the undersigned&rsquo;s entire investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company hereby represents and warrants to, and covenants with, the undersigned as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company has been duly organized and is validly existing as a corporation and is in good standing under the laws of the state of its incorporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Prior
to the closing, (i)&nbsp;this Subscription Agreement and the Shares will have been duly and validly authorized by the Company and (ii)&nbsp;the
issuance and sale of the Shares will have been duly authorized and, when the Shares have been issued and duly delivered against payment
therefore as contemplated by this Agreement, the Shares will be validly issued, fully paid and nonassessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Neither
this Subscription Agreement nor any of the rights of the undersigned hereunder may be transferred or assigned by the undersigned, except
to an affiliate of the undersigned without the consent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Except
as otherwise provided herein, this Subscription Agreement shall be binding upon and inure to the benefit of the parties and their heirs,
executors, administrators, successors, legal representatives and assigns. If the undersigned is more than one person, the obligation
of the undersigned shall be joint and several and the agreements, representations, warranties and acknowledgements herein contained shall
be deemed to be made by and be binding upon each such person and his heirs, executors, administrators and successors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Subscription Agreement and the documents referenced herein contain the entire agreement of the parties and there are no representations,
covenants or other agreements except as stated or referred to herein and therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Subscription Agreement shall be governed by and construed in accordance with the laws of the State of New York, without giving effect
to conflicts of law principles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Subscription Agreement may only be modified by a written instrument executed by the undersigned and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Unless
the context otherwise requires, all personal pronouns used in this Subscription Agreement, whether in the masculine, feminine or neuter
gender, shall include all other genders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">10.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;All
notices or other communications hereunder shall be in writing and shall be deemed to have been duly given if delivered personally or
mailed by certified or registered mail, return receipt requested, postage prepaid, as follows: if to the undersigned, to the address
set forth on the signature page; and if to the Company, to Xcel Brands,&nbsp;Inc., 550 Seventh Avenue 11<SUP>th</SUP> Floor, New York,
New York 10018 Attention: Mr.&nbsp;Seth Burroughs, Executive Vice President, or to such other address as the Company or the undersigned
shall have designated to the other by like notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><U>SIGNATURE PAGE</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">Signature(s):</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">By: /s/ Robert W. D&rsquo;Loren</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature(s)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
<TD STYLE="border-bottom: Black 1pt solid; width: 50%"><FONT STYLE="font-size: 10pt">Robert W. D&rsquo;Loren</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-size: 10pt">Print Name of Subscriber</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 13pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>Number of Shares Subscribed for:
82,159<BR>
Amount of Subscription: $113,380.48</B></FONT></P>

<P STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>(<U>All Subscribers</U>
should please print information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>below exactly
as you wish it to appear</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>in the records
of the Company)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
<TD COLSPAN="3" STYLE="border-top: Black 1pt solid">Social Security Number of Individual or other Taxpayer I.D. Number</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD COLSPAN="3">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD COLSPAN="3"><FONT STYLE="font-size: 10pt">Address for notices, if different:</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD COLSPAN="3">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD COLSPAN="3"><FONT STYLE="font-size: 10pt">Number and Street</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD COLSPAN="3">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 15%">City</TD>
<TD STYLE="width: 20%">State</TD>
<TD STYLE="width: 15%">Zip Code</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">ACCEPTANCE OF SUBSCRIPTION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">Xcel Brands,&nbsp;Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">The
foregoing subscription is hereby accepted by Xcel Brands,&nbsp;Inc., this 1st day of August&nbsp;2025, for 83,368 Shares</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">XCEL BRANDS,&nbsp;INC.</FONT></TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 50%">&nbsp;</TD><TD STYLE="text-align: justify; width: 3%">By:</TD>
                                        <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 47%">/s/ James F. Haran</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD>
                                        <TD STYLE="text-align: justify">Name: James F. Haran</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD>
                                        <TD STYLE="text-align: justify">Title: Chief Financial Officer</TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-&nbsp;</FONT></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>6
<FILENAME>tm2522654d1_ex10-3.htm
<DESCRIPTION>EXHIBIT 10.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; margin: 0"><FONT STYLE="font-size: 10pt"><B>Exhibit 10.3</B></FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">SUBSCRIPTION AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: justify; width: 50%"><FONT STYLE="font-size: 10pt">August&nbsp;1,
                                            2025</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Xcel Brands,&nbsp;Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">550 Seventh Ave, 11<SUP>th</SUP> Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">New York, New York 10018</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">Ladies and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
undersigned hereby tenders this subscription and applies for the purchase of 60,883 shares of Common Stock (the &ldquo;Shares&rdquo;)
of Xcel Brands,&nbsp;Inc. (the &ldquo;Company&rdquo;) for an aggregate purchase price of $84,019.44. On or prior to 9:30 a.m.&nbsp;on
Monday, August&nbsp;4, 2025 the undersigned will deliver to the Company, via wire transfer of same day funds in accordance with instructions
by the Company in the full amount of the purchase price for the Shares which the undersigned is hereby subscribing for pursuant hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
order to induce the Company to accept this subscription, the undersigned hereby represents and warrants to, and covenants with, the Company
as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
undersigned has such knowledge and expertise in financial and business matters that the undersigned is capable of evaluating the merits
and risks involved in an investment in the Shares and the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
undersigned understands that the Company has determined that the exemption from the registration provisions of the Securities Act of
1933, as amended (the &ldquo;Act&rdquo;), which is based upon non-public offerings is applicable to the offer and sale of the Shares,
based, in part, upon the representations, warranties and agreements made by the undersigned herein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;The
undersigned understands that: (A)&nbsp;the shares have not been registered under the Act or the securities laws of any state, based upon
an exemption from such registration requirements for non-public offerings pursuant to Regulation D under the Act; (B)&nbsp;the Shares
are and will be &ldquo;restricted securities&rdquo;, as said term is defined in Rule&nbsp;144 of the Rules&nbsp;and Regulations promulgated
under the Act; (C)&nbsp;the Shares may not be sold or otherwise transferred unless they have been first registered under the Act and
all applicable state securities laws, or unless exemptions from such registration provisions are available with respect to said resale
or transfer; (D)&nbsp;the Company is under no obligation to register the Shares under the Act or any state securities laws, or to take
any action to make any exemption from any such registration provisions available; (E)&nbsp;the certificates for Shares will bear a legend
to the effect that the transfer of the securities represented thereby is subject to the provisions hereof; and (F)&nbsp;stop transfer
instructions will be placed with the transfer agent for the Common Stock;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(iv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
undersigned is acquiring the Shares solely for the account of the undersigned, for investment purposes only, and not with a view towards
the resale or distribution thereof;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(v)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;The
undersigned will not sell or otherwise transfer any of the Shares or any interest therein, unless and until: (A)&nbsp;said Shares shall
have first been registered under the Act and all applicable state securities laws; or (B)&nbsp;the undersigned shall have first delivered
to the Company a written opinion of counsel (which counsel and opinion (in form and substance) shall be satisfactory to the Company),
to the effect that the proposed sale or transfer is exempt from the registration provisions of the Act and all applicable state securities
laws;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(vi)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;The
undersigned has determined that the Shares are a suitable investment for the undersigned and that undersigned has the financial ability
to bear the economic risk of the undersigned&rsquo;s investment in the Company, has no need for liquidity with respect to such investment,
and has adequate means for providing for his or its current needs and contingencies;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(vii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
undersigned has full power and authority to execute and deliver this Subscription Agreement and to perform the obligations of the undersigned
hereunder, and each such agreement is a legally binding obligation of the undersigned in accordance with its terms;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(viii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;The
undersigned is an &ldquo;accredited investor,&rdquo; as such term is defined in Regulation D of the Rules&nbsp;and Regulations promulgated
under the Act;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(ix)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;The
address set forth below is the undersigned&rsquo;s true and correct residence, and the undersigned has no present intention of becoming
a resident of any other state or jurisdiction;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(x)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
undersigned does not have any contract, undertaking, agreement or arrangement with any person to sell, transfer or grant participations
to such person or to any third person, with respect to any of the Shares for which the undersigned is subscribing;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(xi)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;The
undersigned understands that an investment in the Shares is a speculative investment which involves a high degree of risk of loss of
the undersigned&rsquo;s entire investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company hereby represents and warrants to, and covenants with, the undersigned as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;The
Company has been duly organized and is validly existing as a corporation and is in good standing under the laws of the state of its incorporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Prior
to the closing, (i)&nbsp;this Subscription Agreement and the Shares will have been duly and validly authorized by the Company and (ii)&nbsp;the
issuance and sale of the Shares will have been duly authorized and, when the Shares have been issued and duly delivered against payment
therefore as contemplated by this Agreement, the Shares will be validly issued, fully paid and nonassessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Neither
this Subscription Agreement nor any of the rights of the undersigned hereunder may be transferred or assigned by the undersigned, except
to an affiliate of the undersigned without the consent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Except
as otherwise provided herein, this Subscription Agreement shall be binding upon and inure to the benefit of the parties and their heirs,
executors, administrators, successors, legal representatives and assigns. If the undersigned is more than one person, the obligation
of the undersigned shall be joint and several and the agreements, representations, warranties and acknowledgements herein contained shall
be deemed to be made by and be binding upon each such person and his heirs, executors, administrators and successors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Subscription Agreement and the documents referenced herein contain the entire agreement of the parties and there are no representations,
covenants or other agreements except as stated or referred to herein and therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Subscription Agreement shall be governed by and construed in accordance with the laws of the State of New York, without giving effect
to conflicts of law principles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Subscription Agreement may only be modified by a written instrument executed by the undersigned and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Unless
the context otherwise requires, all personal pronouns used in this Subscription Agreement, whether in the masculine, feminine or neuter
gender, shall include all other genders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">10.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;All
notices or other communications hereunder shall be in writing and shall be deemed to have been duly given if delivered personally or
mailed by certified or registered mail, return receipt requested, postage prepaid, as follows: if to the undersigned, to the address
set forth on the signature page; and if to the Company, to Xcel Brands,&nbsp;Inc., 550 Seventh Avenue 11<SUP>th</SUP> Floor, New York,
New York 10018 Attention: Mr.&nbsp;Seth Burroughs, Executive Vice President, or to such other address as the Company or the undersigned
shall have designated to the other by like notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><U>SIGNATURE PAGE</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">Signature(s):</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">By: /s/ Mark DiSanto</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature(s)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
<TD STYLE="border-bottom: Black 1pt solid; width: 50%">Mark
                                            DiSanto</TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-size: 10pt">Print Name
    of Subscriber</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Number
of Shares Subscribed for: 60,883<BR>
Amount of Subscription: $84,019.44</B></FONT></P>


<P STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>(<U>All Subscribers</U>
should please print information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>below exactly
as you wish it to appear</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>in the records
of the Company)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
<TD COLSPAN="3" STYLE="border-top: Black 1pt solid">Social Security Number of Individual or other Taxpayer I.D. Number</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD COLSPAN="3">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD COLSPAN="3"><FONT STYLE="font-size: 10pt">Address for notices, if different:</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD COLSPAN="3">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD COLSPAN="3"><FONT STYLE="font-size: 10pt">Number and Street</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD COLSPAN="3">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 15%">City</TD>
<TD STYLE="width: 20%">State</TD>
<TD STYLE="width: 15%">Zip Code</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">ACCEPTANCE OF SUBSCRIPTION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">Xcel Brands,&nbsp;Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">The
foregoing subscription is hereby accepted by Xcel Brands,&nbsp;Inc., this 1st day of August&nbsp;2025, for 61,779 Shares</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">XCEL BRANDS,&nbsp;INC.</FONT></TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 50%">&nbsp;</TD><TD STYLE="text-align: justify; width: 3%">By:</TD>
                                        <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 47%">/s/
James F. Haran</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD>
                                        <TD STYLE="text-align: justify">Name: James F. Haran</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD>
                                        <TD STYLE="text-align: justify">Title: Chief Financial Officer</TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-&nbsp;</FONT></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>7
<FILENAME>tm2522654d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Xcel Brands Announces Pricing of $2.6 Million
Public Offering and Concurrent Management-Led Private Placement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEW YORK,&nbsp;August&nbsp;1, 2025&nbsp;(GLOBE
NEWSWIRE) --&nbsp;Xcel Brands&nbsp;(NASDAQ: XELB), a leading media and consumer products company known for building socially driven, live-commerce-focused
brands, today announced the pricing of its public offering of 2,181,818 shares of common stock at a public offering price of $1.10 per
share. In a concurrent private placement, the Company also agreed to issue and sell an aggregate of 145,147 unregistered shares to certain
insiders of the Company including the Company&rsquo;s Chief Executive Officer, Robert D'Loren, at a purchase price of $1.36, which is
equal to the closing price of the Company&rsquo;s common stock on July&nbsp;31, 2025. The closing of the offering is expected to occur
on or about August&nbsp;4, 2025, subject to the satisfaction of customary closing conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Maxim Group LLC is acting as the sole placement
agent for the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The combined gross proceeds from the public offering
and concurrent private placement, before deducting the placement agent&rsquo;s fees and other offering expenses, are expected to be approximately
$2.6 million. The Company intends to use the net proceeds from this offering for brand development and launch, working capital and other
general corporate purposes, including payment of outstanding payables.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The securities described above are being offered
pursuant to a registration statement on Form&nbsp;S-1, as amended (File No.&nbsp;333-288495), which was declared effective by the Securities
and Exchange Commission (the &ldquo;SEC&rdquo;) on July&nbsp;31, 2025. The offering is being made only by means of a prospectus which
forms a part of the effective registration statement. A preliminary prospectus relating to the offering has been filed with the SEC.
The shares to be issued in the concurrent private placement were offered under Section&nbsp;4(a)(2)&nbsp;of the Securities Act of 1933,
as amended (the &ldquo;Act&rdquo;), and Regulation D promulgated thereunder and have not been registered under the Act or applicable
state securities laws. Electronic copies of the final prospectus, when available, may be obtained on the SEC&rsquo;s website at www.sec.gov
and may also be obtained by contacting Maxim Group LLC at 300 Park Avenue, 16th Floor, New York, NY 10022, Attention: Prospectus Department,
or by telephone at (212) 895-3745 or by email at <U>syndicate@maximgrp.com</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release shall not constitute an offer
to sell or a solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in
any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification
under the securities laws of any such state or other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About&nbsp;Xcel Brands</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Xcel Brands,&nbsp;Inc.&nbsp;(NASDAQ: XELB) is a media and consumer
products company engaged in the design, licensing, marketing, live streaming, and social commerce sales of branded apparel, footwear,
accessories, fine jewelry, home goods and other consumer products, and the acquisition of dynamic consumer lifestyle brands. Xcel was
founded in 2011 with a vision to reimagine shopping, entertainment, and social media as social commerce. Xcel owns the Halston,&nbsp;Judith
Ripka, and C. Wonder brands, as well as the co-branded collaboration brands TowerHill by&nbsp;Christie Brinkley, LB70 by&nbsp;Lloyd Boston,
Trust. Respect. Love by&nbsp;Cesar Millan, GemmaMade by&nbsp;Gemma Stafford, and a brand in development with&nbsp;Coco Rocha&nbsp;and
also holds noncontrolling interests or long-term license agreements in the Isaac Mizrahi brand,&nbsp;Orme Live&nbsp;and Mesa Mia Live
by Jenny Martinez. Xcel also owns and manages the Longaberger brand through its controlling interest in&nbsp;Longaberger Licensing, LLC.
Xcel is pioneering a true modern consumer products sales strategy which includes the promotion and sale of products under its brands
through interactive television, digital live-stream shopping, social commerce, brick-and-mortar retailers, and e-commerce channels to
be everywhere its customers shop. The company&rsquo;s brands have generated in excess of&nbsp;$5 billion&nbsp;in retail sales via livestreaming
in interactive television and digital channels alone and consisting of over 20,000 hours of content production time in live-stream and
social commerce. The brand portfolio reaches in excess of 43 million social media followers with broadcast reach into 200 million households.
Headquartered in&nbsp;New York City,&nbsp;Xcel Brands&nbsp;is led by an executive team with significant live streaming, production, merchandising,
design, marketing, retailing, and licensing experience, and a proven track record of success in elevating branded consumer products companies.
For more information, visit&nbsp;<U>www.xcelbrands.com</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This press release contains certain statements which are not historical
facts, which are forward-looking statements within the meaning of the federal securities laws, for the purposes of the safe harbor provisions
under The Private Securities Litigation Reform Act of 1995. These forward-looking statements include certain statements made with respect
to the services offered by Xcel Brands and the markets in which it operates, and Xcel Brands&rsquo; projected future results. These forward-looking
statements generally are identified by the words &ldquo;believe,&rdquo; &ldquo;project,&rdquo; &ldquo;expect,&rdquo; &ldquo;anticipate,&rdquo;
 &ldquo;estimate,&rdquo; &ldquo;intend,&rdquo; &ldquo;strategy,&rdquo; &ldquo;future,&rdquo; &ldquo;opportunity,&rdquo; &ldquo;plan,&rdquo;
 &ldquo;may,&rdquo; &ldquo;should,&rdquo; &ldquo;will,&rdquo; &ldquo;would,&rdquo; &ldquo;will be,&rdquo; &ldquo;will continue,&rdquo;
 &ldquo;will likely result,&rdquo; and similar expressions. Forward-looking statements are predictions provided for illustrative purposes
only, and projections and other statements about future events that are based on current expectations and assumptions and, as a result,
are subject to risks and uncertainties that could cause the actual results to differ materially from the expected results. These risks
and uncertainties include, but are not limited to: general economic, political and business conditions; those factors identified in our
 &ldquo;Risk Factors&rdquo; included in the Form&nbsp;S-1 for this offering and in our periodic filings with the SEC; the ability of Xcel
Brands to achieve its projected revenue, and its continued access to sources of additional debt or equity capital if needed. While Xcel
Brands may elect to update these forward-looking statements at some point in the future, Xcel Brands specifically disclaims any obligation
to do so.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>For further information please contact:</B><BR>
Seth Burroughs<BR>
Xcel Brands<BR>
<U>sburroughs@xcelbrands.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tm2522654d1_ex1-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2522654d1_ex1-1img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !% .8# 2(  A$! Q$!_\0
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M!&",BF^5'_<7\J=BC% #?*C_ +B_E0$53D* ?84[%&* "D**WWE!^HI<48H
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MVVKLES=Z<2T6R0F)&R?F487)Y[BI7)RZ[_\ #@[WT.NHHHK L**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
)BB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>xelb-20250801.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaGHubOdzZR+aYkxtmBybdl6vywhWS8m8SFiXDMWMegA -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:xelb="http://xcelbrands.com/20250801" elementFormDefault="qualified" targetNamespace="http://xcelbrands.com/20250801">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://xcelbrands.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="xelb-20250801_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="xelb-20250801_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>xelb-20250801_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>xelb-20250801_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="xelb-20250801.xsd#Cover" roleURI="http://xcelbrands.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xcelbrands.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 01, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug.  01,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37527<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">XCEL BRANDS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001083220<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">76-0307819<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">550 Seventh Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">11th Floor<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10018<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">347<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">727-2474<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">XELB<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2522654d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xcelbrands.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm2522654d1_8k.htm">tm2522654d1_8k.htm</File>
    <File>xelb-20250801.xsd</File>
    <File>xelb-20250801_lab.xml</File>
    <File>xelb-20250801_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2522654d1_8k.htm": {
   "nsprefix": "xelb",
   "nsuri": "http://xcelbrands.com/20250801",
   "dts": {
    "inline": {
     "local": [
      "tm2522654d1_8k.htm"
     ]
    },
    "schema": {
     "local": [
      "xelb-20250801.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "xelb-20250801_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "xelb-20250801_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://xcelbrands.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-08-01",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2522654d1_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-08-01",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2522654d1_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001104659-25-075178-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-25-075178-xbrl.zip
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MB?T4N;0G#B96?'%[L(XGXC3JN_ST27A.1ZX486XI,DV^8XOQ(QAR,PR/>G(
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M4U3#<73J]@U'@0^[H338!C*:5&4%O]XR4L3M5C6%Y0YN_='M /Z)X(>PRQ&
M+E8Y;-,!NL,[K?+A6,#)P):D&(X[40 U\ZV/ CC/,$L2!-J53&X[?% -;X7
MP/?2K!P#.*.QS"7 _A*0N2PTDM!RLFM8-""9J,IQ!F" +6;10.FMF:WB _##
M3H0?# $IX.ZT6R*-L@'<2+X%(XVQYE483A5%)6D #]8X CR2R%+2\_9@\-0
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M#IC8?IQ2PI\F>!U25!GA#QPI.X5U9C$0G+AP]\30R&5WX#"0CYN(&IJD[ E
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MUK>WK^^<\FZY\G.ZF^LEO;A_36O%6G0&7*D81Q^ZT6]2YN);(MN3(]B33;4
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MYOP"+.,2_T+F0H4Z<U4NJJ*K<.AX,79MW=-7>_VQ1OMI*[]C:VO>KE;P0OG
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M55X7'>[3X<' (3=VKO%-)ART1O<9IXJ[>%0=\V)32,:%S/ZSZVD.[0Q62O0
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MN_X8<7:J6HR"8HK.I&%MFJ';&&8TKD/VF5/D62);"M.%B"8:-&;FAD8?B<J
MZ&-RH59D(/H$$WR";$$<LF%DT\_B"&&3:^E;>D3V%,HJ96D\-UYL OU:?*A6
MV9^[=K.F3(HT<AV[Z@PE:-H(57K\*$&CE]@^,F83"B17T7 2:1XC,1/WE"QX
MAI.(*PQ_&QQ82M:<U+"BMV(S74+W1:5F)#1T?(M((L9"$WW 2P1)R(*I77>(
MAH/JUQ@'=."_"LD)F8T,-H<3^&[7X>9!, B"E_.T:&7_>LFZ=2;AN3<)I<VF
MN((F#S$/_I!HC2O$DA>C^[P/VUY=AQ-EK.+@#\Y6WRV)6:GXPES@JNT'(KDD
M:!@;,>#I5>VBFDMESD2[[2!;;'DA Q_/,>9B*&VUKMMM63+\$WGB/7C]G*#K
M[-9H#!*I,VFXFP:'ZH<1)R,$3LKD2.NZ:%PZS8S$)6 2G,B'!YQW1C=,!MF/
MN"[CMX;3,5W3W #B)U#.LU-K ;O$V>4)AW(&B@EL6E9,!DQ;.#WE[^3R,[:1
M\3"1:-FK&P>TBU;U9:L1!90[EY7 D2VKCH:UW/08KO#07/Y([C])/?RP"DY#
MUHSNL=A="@KXSSFRTNF4F&U,-4K6L;+B >B!(<N,(CH4&F9>Q0J!DN^X!76'
M?* @N&8_1(AS+;^ ?U'121)PC)<B=IX2!!D"/=S50\<4Y!)&2OJZ&/H6.Q/:
M['/.NZ7W$]AGF@'J M 6"]I0,?T\AJZ<J&EMEG8B5JHP33$QQ^16]]3O9PHY
M+>VSJ:?<=HIIW)&M1MCO1(J+LMJP )3[<*N3ASD=-AYPL<]+AQ42N,>U:1F*
MNVTUI<=9 )@9MT8S/+73<PE^#DYI%ZO9T2193^^3"G96AFQK>4W&R<UA2K6Y
M\)\)?DFS,-EJ>_O3(7>,&,?A 0C!_?YQK4WDQ;4.#@-O:PV85]VFF\E=XMQD
MG]D+)#?:,W?2*TDQT%_,R*[UB3*J;3@FRL:BK(:7@9]!'->,1_P%UF'\4#+E
M0R<$_ ;2E&'*UL,\<I_GU[%\YM&Y)@&]X^C@6,L5<C6Y-1]-F/OK1<= _[YH
MR][#B3U\C(!CY;QB<\DK.HD[KD$ AG;%^D29#/GN;8/6U=%E@A\)/@&>LZ]A
M,5M*]8!3A2N!Z38.X^4?&5XS@0$7#X-E7M<51Q?YI, PKPUF*UEQXP]#HA;'
M^%7PIE$F.;ZI>R.&[L[9NY0F.#,!1-'O$BQ82Y=<N'&BLA2SX/_&:+8TH8&'
MH@2[EO10@L3_. XSHHF>E<,5;A,*$&C7<Y;7"9",G>L-=GGV2^7^\-6E<G_X
MELJ]*?[UA:G /'MR>"!^[R.3CW->2B*9BP8^.T7,9B15XOW\HD3<:4^ML!$3
M&S6C8/7CP&=14._P@)\960U37-C.>PJ]:!^MG^Q%<^\[3W'39?<>.M#C(%!B
M&(E8V<-5FVW+HNM-:P;G+ H(^4AOY/ZB)70=>XI:[*/SN"I"_#K<+I*CEJPH
MCA-70/DI.)9U?'AP1-E=;5'K_M+'J8GRPT4UJVS* 6-M;K6#PKW9UA=9^OC7
MT)Z7M$<NG1(3G4=Q1T]VG@LMFTUM!MTB)/PJJV+Z$OFX2U"X<JJF7M79HC=<
M>1B+]ED,F0)<#8M_**T[7JRD;]"=IR!IN9!^C.;U8B)(^BP9YTRFF1+9RAT"
MBEZ];U85F!?1>"2E1Z?"M;Z1"%0BKH[XOF2(5 !2Z2CI1P36]PVCNKXBTW'4
M;/\PZ@A'(OX&]9EVF#_#G__@@0N93:;$<JU&I,BSJ^5TU57]14EA;S% V!J6
MD#GVZ<92KY(T Z<NT?A<N#B@*$=YUC/0A3*TNX<'SWT@6)]K2<)=^ND=(3I4
M&YM5CJQEV],H*<_;26E6.]B#)*0I$E-BF%#^]8@.,RS-X(5A;I\%Q1H9KK@K
MI/$)XUV7@F Y :T"4I&<O*%STVQQ(M4=LA$9TJ8YZ@P\07Z>O@P#SL^:CS^5
M\2$F"3M\P-GB4K[%IE--RQH>IW*)U1D+V^7OSZ>GK\-^:KXEK)03^))IWUVG
MDGY^Z59.<AV!M):A>K?M>A+]H,*61-LPT8+^3]L._%![->$4^(0LBZK#5A^2
M;MB1  K$E9HCIJ+R>.A(,!NR5$G7!*7$0O38+%Q7(5+X K%9^DLH66;*$(2B
MAV6LVZO>/4/W:T!]2MK?-9=S21]%J/I5]&M'GDR#Y[:&SZ]T^J#I4 7<*:F@
M$1'9!@9^@SV43S,:*V\T*K[V\. )W6Q@.?[6"#\/+-S9)2_:BXJK>B2*\[0$
MHZ!=&Z/R;4B5)]*"X6;0L#N%V:D]//"(!1G=G?[4[4KUY$%^A<C(>L?^1TB&
M7*G)*+Z%A?IN%GSL\!L7Q2(3= +"4K#,X;.0RGF4;1GEHAK#EE:;93["TPUJ
MBK.F(:3?QR./3O79R!L'U]<6U;]DH^?S#@,9..(&(=KN7;)ZTE"/<91\9FRA
MO2I-TL1P,0ZH/8C'C".T1X_EW7;8,3:42AJ7-2]9E2[,3LJ%-?I1C=&.J6"2
M8:(P2>*;2ER]>191:L9K7]32111U*IC++563^BL%'W"YX_M*H2>HU07#';@7
M*(/H%Y@MTFHT"I?U%SY\X_@+,$@]A&$1&S1:Y!),Y/2+>Y,)^Q@6.1J-!A^#
M[ ,I["#T0]NX:XHF52HD.>,P><N=PY2!AP->ITO<'L0A8'LI.L!V1Y5.Q'-M
MCE*5NX*A"E/B ,(8<;35.EJZ.*@M&*I 4G0#8H44P6*R^8Y/3>\:&PN/#,]Q
M.BW$WWJ5HV=CFY.5G@?6,^*=)U42;H'C4J3$5-6S 4'UTTXG685$GW<?WDEN
MVG+_FA$=S\A/4Y506J:'W!1LY0EZ"'R\/]:>$X)KS*1Z;-1]UA_O9.C V+<C
MI'* J*$%"@CJ*E$3M,9TD.A'I_9=EG.]F<$[D$?/#R9P%11^_+38AK2CPF--
M(YD<P*VS)7[WML0+V(_S"-R!_=()Z%)(754/2@0M-=SX;:[0?SAA+M:>&Z@@
MIXPNX2!KJ;<'*.X1E/:X0-A$*01WI4WJ G@D89C9:2TU57@D3+&B:""NO7(U
M"0A+G%4#%6KG0>$!I_L6R!3+0 ),[9QC6;B)(2%DWA<H',5U#70_;4U]@W#N
M',=X=# 0O#MS.M>M\6W+A6O]&C.'\T^3%,HAW<J^Y$E,5<M;>'@PO8=\I?J+
M16X;]2-RR< Y:X]"&1).D*S-J?(+H8]'N12L6JM6@=A1W*7MO,(6I:.))8P-
M)HLDJ(C./0\#VUP8!U?.9LY5F9O!94BMLI%LY5B*@WR]-A"5&(=!Z-I;B!<J
M/"MC+*Y?@D3F5:(G(E KC+>D%C[<('=+ZRL2EH.!*[>^I'E17H]7YIO<8FY\
MG"P98QXG:*?1/>-@T@W6SOOEHG[\ZG)1/W[+1=T44^"],06*&;;_?%-*4)&#
M!+!C-?X!;:LU$A$XDW:/NQPIN$#)-,XCM45MOM;.PQ2C!^Q[V>U3?0PS:>(1
M6@:(V+!6?A4W.*2]P !^B53SC*3?-,X^)F!;*4 "&+)^S;VBTW6]J-;)SI01
MKD22$^-[F2G<9?GB45L, "ZRR0AE,Q 7L*<"8((#WXRBA,%39\CY<NE,93:M
M_'QZ7W()?_';B3 )).&#"^<Z44'OR_6]3E];*2J)BDDTZ)Z]"MGZ9LS^/L*#
MN/ IUF/I+WG,=$<I^"@/?% F>O DV"V' F!U!L[.>(1YX9N_8@:G;>Y@*J <
MJO"O#AG*EZN^-H#SZ$<<DP&UHN?>+=2RN[AL'9$MN##=0GE:#/T*6,U$96OF
MJ%P +*JC=7>.N\OQC'<A)7QRK+TYECCT+E\7Y%0'1)5<+R77"BI*7  WNC;_
M G_[[>3MR40ALL3"T5)/4C@$=$IF@2D[X'_4&!S&LJD*4&B/I*D6K4GT[2NX
M;?AS%QCINY;_,IRUX[7,@S[O[)O1MXOS<R3D'8A@0Q4K-LOX"#?B!MM>GW8=
MUJ;TP2VF>,;[N4BF+)SI5I6VAVU:7O] )QU)L1T3^@01I'&H@P'=C++,+?$/
M/CE)89-+Z,;>D3JF_0SQ8W;[+B)(!1H+T<<1I4& <Q\B4#>+IL)<4JE%"?]L
MUT>=)-PHD'8\F(QY%!J>4-MZ?1KH4 .;31-;!40LU1 I.1,[<'0K1W 0Q2L2
M54E-&FA>-!0_">?G\NX%Y*+C"=.+/<&-(;41%H9TR"+-F0!;9$D3+"E;Z(*G
M!H&:<$,*8L-4K@N*#I81<D8^G:9J,# 9UKC(N42,;G)94AZ4%&P>Z6!2?JR&
MQ\QUQ0<\^65S676MOA2V:2@E9H5G:*WD6Q=E41,Z&R'JRW) RQ(^3 S)1'\Z
M;,T?8^5-PR ;6"ZJW-#K.,))1YFS!YNPMUF%_NAKT:\KKU_/[-8='KR '4ZS
MHX_N>$_R.+KL8VCQ=;>Y%:DU6,H;1QKF90GE^V(#ZZ%B)&$((WN6!:I8S2J2
MFJK#R&FW+'!<N+]Y=MZAZI ?:JY5YP^0_3_3GRAT4AP3ED>?.QIO*=&;GNW2
M"]@=W"SX",A<*:@%5V/M?[W,YA?PW3EAV'C27.I#T 0D7E-JNJ']4,U)SU\4
M_RRZ1;MA,)>@B%KLR]@/G/>T(4P?O_R+^YY*> @SHWJ>:#%SI\D(I&&FS"$V
MV(D-IF7H,J"P<]]3XL\F[G(L?<=&8I(W0D%H.S"IZ&/KEFJXJ-J*8&JD"9M%
M+45[B6$3=.P*<4E%S^TI I8<6KX%KC_K:_H'C'3!*\G_SNI2](=G+>L]F5F/
MF:<YI7TUR-[+[8*7J?LRW0.X=TB3-V#AE*L4,)9I[M#Z%.S!?\!BK3;UN?8.
M8"Y;Q9OQ56R@-,$!S?1\ZM8],G<8*3N]^WEQ9&QN0OYV*AS7KLLDM=))8I0Q
M&@_!<MOOR'H17(R(4/?0%2F+W%V!1)Q-DW&[X]<.!L7FN+L(B%@M)A#W8\EC
MP[UO%2<V]PFV9)H0%WD?8_[KN4P:?YF\<3F8PX/7+'KIRX3BQ_8R 5704W\$
M1!QZML\^8L&2&EB1ZI W@V1AW6'BW-T[$O0>YWM2Z2+"8%@&A3TD'-71[K9A
M;*-@""WA,.JTC7Q;\^6S0FU6B7BLDMD6#\Z;"'&E^G9<$();_(O",Y!AP:VA
M*8GIC9$3?^Z(S%;MPC27D#/NIL%#O,'G9+^$PKV[7UU&X=[=;RF%FZ*66Z^6
MWU4#LGC!43PEA,F>.IGL"6K>PCQNR!G'?3?Q>13W1*:""NY-4F9<!\,.8-1<
MANP*XF2 QS%^-?4\,5EZ\A8GGL(ABM[$CUG#./A= FX;3\WU*#@\()]Q!W.7
M<S*7Y+?+HC*I%^I^YL/6P2"^FI4OOA(,DXTOF73SX8J4Z'OH8\"_L1K%IR4V
MVA*2;CWX/B%+.=#(F)SXV1,M+L+@;,!CP5-Q(.%BZ\AFHC" ,QW%Z<>O"&.N
MN7D1N--=EA:E+G AF-D$W1QA%(FDS@P!YZ8-%WIW.R%]9$-%+-RNUQ<_K$L0
M&BX./:50O14AAG'/%6EY <=>S%QRQ_99-I!:Q"#@-U44^0E4E9MS&S<&YE'@
MPC12$)>/YCHN%TWO46PGQX8$X^3%DMC'8OC*0LAK0Z@(!XO\X@T90"(3'Z$$
M<W9,?>4R+"?YM:2OT+,G5%_!Y5>>BK/G%MHEJCK[[_ S8*-R<^K,?BYK"EH1
M_J%';W8@O47$<N+IKK<\(.^QFA+#RDS;GP29 04]@C:&ILD7N[#B%>*9I39Q
MR>8MGVH7<V[%G05O$L-JB*Q>?7ZV.4$R:J(B5BXR%8OL#:U&0#9Z>/#*P\:O
MQ=)+(=MG6-5J4Q]==5BX%O8(/A9N!XZ+\YQVS82>#>M64>Q!.?TY]$#JN9C!
M0&',"TWAVD7F+U(42K_)7S1?XX R+L55FQW=EX/'%:/+KEU%M0TAW-=7*'Q,
MU'9"F6GSK[V[$-IUSZ5T+1SMEZK$*#+=S'%2)@BT*>.1S[YJMG_W-FNK#;IB
MEUBE!<M!K2+(_W)='3P[RZ<NON?5F$9YQ"GD!/ED+?W0=LX*[\&@)Y'C*&%L
MK /#ZYS)=" \:<!,W6I'2=Z:7>_\PC+IER2\:KAOTMC@YMY][C6EYT!9P>\V
M'>?W)2[.D$V\'+ W4@24R(22EVU0WU2W"N\&RL$X/'J0WC:1BH4$R3XIG_VQ
MQ_>V&2/_L,8([*%)9U]K@+ EB!O/;3KIG]B*;5 X4"\> ='<S=MS:C]K]!1>
MT%B2)& 017/3X:LI ,4>65?U[Z5#J=1A%BN$2]-ECL-8=YN%9N+F,&%8+:Z(
MMOX7%4M]C)E;-N?@?B],AA+;^'!+&-=T"GG*%JY7'1DY#)+I>44$;0%B!,_Z
M*/7/N!Z45%Y&@["JT-I6TBRZ\MC1[<H&A 6/KU$_\2!HT<C(*64UW5_X4N74
MD&L!H-:8^Q1=G8X@Q^V[KZ"-8Y4$, J;]&JFMX 'G7.[+T(L85\AM>GZVW?>
M.A/[,%1^AP=_0[/5U5?Q!ITI3DZ1EAZ?Z&2,@)>N4^)UK7K8E;T&1(7X0?^F
M*>QEFC9+RF.H6-^##!%[9G@)4^#&Z%$![R\:^N*)D)2Y(>5^'9BX5A;BV')O
M,!A"(7L!ZD,23IXBC%G'N%F/Q!V6FZZI^@N")Q!_FHR#>09GVSSZ3L>Y*%)Y
M'-@?QXWXNWB,XF^3OFJ[KKV23.,*MF++)PX!/*60=;F_\*-L-A2](RJ=YVA%
M;]XV7=D70%+WP^X25*]TK9]]BZ+1"SS%9? 6TG&:+T;+@"Y_1#**N8\PGO&S
MA@Y.6%GFMK(29%9AMQW)78/?"= 7^,.'N83A_N/>_;OYW;MW;=5M$$8SH9Z^
MJ,7SI$YU]<"MG*3)A).'#@O7.W(Z? BK*ZO5#,MPN;BA[1)UNUC345X4]3(5
M'S0)2FFFJ*LW U6_K(: 9L;66V)QE*LD]7V-1R69<>G';=.XO=>X;XL.7,.R
MO_/J0UUN'R';!\@;GLQ3SSCQ!%5%FVJ2LU\XS/,\4KEV7=M\=9*!.QC5X<$I
MUSC=OWOW/M/1K(02@9WKSO9$B/AQM7K*T98G1C#-$6*S_[.M*U?2&B # MAW
M)#P ?W,8)O,]EG8%Q@<:(,B<TV_AS*^XN%?VS+"$S&7/_,URWK(.]MK5^"U%
MKR813L3VZ;'LNC0_;8D;Q(8%&0SR6O"UX3#\VJD5%8.V28UA((8Z('X=&LD=
M.NM%E._E!*RPJOC*M@F/7PGA'<!:P]A,#50)P0@UCY-5=/7,%A$Q)W5)M#!4
M_HOW.PV$@C1-O?UBRZ)M@VS5NE^,8(BD1?V B 2HD_@&&RQB^6(W6?I4,=C-
M)_EQK9QM@L WLF9/-U60LJB60LO5[QFBA3NRQV02V!#EPA8(.*&5%,J\7) /
M?40!RB5Q2<'Z!@5N;_SIO?==<>?>0]?V"Q]R[^&"?W7L;(G K4_F6Q8E&N#E
M0O"IUX\/8V]D\HLK8@H;IDJ_HRR&8Z 2;CKE9.H%Y;8*"="#%: B;!8,!^YB
MOI@57!;:5$B>C'_0"* 6DBO9C./V<:/QNL[7Y(3:DGCS@GV/&L%NV6H3FY2"
M"27&.92U*]V\Q2\Z-<U)KOH>N4.C:8FI0GJP,MT=.6]^)_:@4-=F"J,M.&))
M<:U/#"*,YTK<X_#G(%0=G!9Q$UC"KV/F1^;379SN U>Q@!'46ZZKU(X4,_0Y
M]]B(*>D'_Q^Y.Z0\&FN9W)3M^D<+8:ETHC]I(;!/2B*],=/V: ##77DRJ SW
MTFI_7A]J:E$(9(=JEZI D\0+=SS%_Q26['")P64Y3B5S8)ZRH":B5E?OD5R0
MKIKH"_GT=++4;/88WPVV5_<$X]S[^L X][Z!<6Z*>S28@B90F&1N/W,A)T.>
M0QZO4%'%J 2)%;P&Z6-/]_1<&7-F7?N>HX8MG7&05D\159:^-P1#U<D,1OA&
M5==4:S;QQG'$2 PT?E]NU$FQN*QZCG*( U_@V'@L.?K ,NB"!\UT"YRM*9KW
M%%S ?_B D61N4D0\G]:?@R]'WX( Z9W ;2.MB\S[KMF%F-B14:KKF/H;Y?&$
M)V?&?5%MO,%.J/?[3"G  0YQ. >Z1$#;!WR]S*HFD=_%9BH?_XE+$S3>H9TW
MG3]<#(6C0U2>B)%'MY(W^';XM..ZL?D:E5/7RF"JL6_ IPKKZ.+,#@U0K5;E
M G]#=_5 C5CF9;66?C5;%[\BH]/W9,E,%H+*8C 9,7Z!VHCF;$7LK<9,7Y5%
M8VY_/T\W*PF1W/OQP5T;(@FF3@T-N#D:0:6#[ -!,Z3_:]]J3L5.AMH^[#-P
M _0*&AH[8Q7#3'O/X+;)ZV4 P3>4+Q[,XFX9]'N=QYCHS12U5:0;Q[3[;"9:
M,V$*BHHNQO?'X4%X@90>(9G>RYA#6HM 3#N4:Y(DMVZ'KRQ7F 9>8'M^Q3A3
MR>6@;TS8,]!1OK<0^1"XY*7MC3TFA[]_-#/D\/==+SIUO"R9MZ>CM0R('-QQ
M[&4^ "(=IR1!S.R-/OU1]<:S83R$<R,9[B0P).4]"BF.# &SF_.$/YNJI1X5
M-FB1@L?@6$8H>\'2>/S80"^B?VA'EVRHYYAW[]W'5--PL8-D/Q\5=KML4]38
MNVVB#CR!!-AZ8^S\S5@P4+.#[\/KSF@1LDY42KTZBL435$K[B'<< !7!'/'$
MT]J$8TX+JV<E+^&45-)7#'Z P75M4\W9WEG2!G?MYIS'\;0D\F4L[GF'>:Q0
M44C2TP8,"??-,6[N#J#==Z.Y*\\7S-_DKBB!69:N ^CDZUV7!,DR^1$<'J2&
M<)RR\CB]-UZ!6Z?S/GB==^H!LR1 [T"[4#SCM:L/WI%*>MP6'47JGKH<OH%:
MH?GBTP!*MEC1G9,'?/^<?(1?V=[H+O'=2H<W[F#'W-^Y905>S4@Y$$UC6^$5
MND9+Z"A,H@>\MY)1=*A=S34>>S?)(40PNWMGT(7Q[<^F>UR:0CO.^5CI)UE5
M3 K,:[!=2XZU^III_);"P0L/HNT)GZ05&^0:<G4EVWT^7Z:NK??-*&LM$%\Y
M8O:OT=%<;FHPA6M1FE70N9 ,9FGYYC\@*^H79\(O\IN38DT8#S)>8\.$.^K!
MX.PK-S%EN\*2EXXHJD8$NC?XF.\9BKO_]87B[G\+Q=V46V7K;Y6G+A$A8$QQ
MD5(AIX"N+%6F_CG!%ZO*",0+KQ"8OQ805(,#, ;AL8+9>%M.\$C(B=JQ4$Y>
M;-FQ!FV5KIKB<:J<F[ZL/;3")!UE-!9TBF&^H4)F&N[C2&Z@_Z5;,:J(N,/D
MT$$>4UA^V*+TV*J1=YILM11!9WU+2K<WM(K>@C5SIP!$ATZ&H.,]!UI,/:UM
M6NCBL+N+B$VGDV-T>V2&S)U_(^EPO,9E:.A/Z\BDM[G8YXZK/AR3$'Y08^!*
MJ\I$6*G&<[<@HBLQV]IP']QJO@G+G/)(08%+X!E^=W)?O)$;? ]]FF+XIU<,
MH+41M'1.;<(.#UXA&@$D@"W,4[C15^J>%<@15LP3)TRO\GCWF%3.;=_.I<YM
M_9"+/^99Q#SI :W^3TGUX Z]UQ.YB^HRB%]_RKW\M3A]1@T4M0B[B<<P:R;<
MOG-":IMO(#YALPT^*\UCHT98AMI>@TAH+\JR)YH(2*^\RFV2=-H@4GG]WJCW
M+KJ.ZTV'5;2N%,82XZ/USDA'3RSB&^3J-T:^MM*C&D4[':I"!\$[W1P5P0G<
MNN-4%,<9'*7_\^;L[=F;OYX]_?_H]-RV6<YF-,MWQ0>*FV[ZT))8>K8R*^1[
M%M#LRUZVNXM.V,$\B3X@_.Z1YQ'R'1]\A\NPG]@D11RZ?JO282*5;H5_S:'"
M):("+_"J'V#9NG+8= TQ9OG*4&X/4RBWI^_*Q:1\7=4OJKGVB[0\@JZAE:5%
MZJ5',I(,8>TZ#V/,TI=Q^V3?[DW8O#P2TUF!N.)4')-CQ\NKA@\S!P ],@LK
MKZ3X(S7-PX-@GA$2^4(J30O8I](9>&W[OC?.O1$-V+%_;(C\)JSEU^(O;\'B
M&K R9)06!BNU-Z3:NZY;F*YO>A8T;3L'4*=Q2_--0\O/KY5NY&XPO(J<0'6,
MP;1RHKSA:Q0:\?R)RY$4>)Y=7[$QRA#(]TPN LTR_#4FT*F[W=(@Z#$B!V.Z
M=1IK/B>-]8P/)AH57;>!![U6;EPI@_GH3A2310PIPFA21>>V0.3P8!V;+&G
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M;[EK<0EVJ?3>F2M0H/44?.OVBB:^,'926-@C'A.QKZ]6"@/X-$JJS!$D(,B
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M@#"GJ/IF=[V&??)M$;_O4/RTG9TMO?05>]Z018+:G-,OC)(7<CE!RV=A9[>
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M)[/^"X8>/GG<9#N% Z?L"M[.9#GQ\9@5?<7=8&C_KA.EW$/CG?C'>]Z5*ZY
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MF';L;0@;"6,/8S@P/#F\V,G#4X84C@U0M]WH[M3J4&^Q6?O3I.[1""E7LS*
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M6_O8LL39XW_?*4"=(D.\&$?7Q)0HN$6?=#X<=]];E7<6Q9;]T%Y;LW'@T;F
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M%PN*YA<VWB)CZV%["D*4HONB'4'I0;(.Z)</G(J2AIX/?_KN;K8^69WPIX]
M( X/_MYV[[,GQ'\&DSH.*ZS OC*4LGS'?1@"\RM*,MW\1:$)+@I-9PHCGYT3
MH9@P'R9IX<2Z9:EE:[;1PLW-PO4EQM.RH_MDT3:+?2Q:4[@!ZXK3YZ3,DH*D
M>)_^=O+V)&.3E: !';SEO"%R*0S;-V2U(K]*17S)W:7L@>/F)2PXPXA=VPQ-
M)*B5>W6!-21V%ZM1IV4Z1FRPZ XYDAL]Z%S)&YQQ#]O[V.WDOLU#>SM4Z4-N
M*76*,4.Z.1YE?R/DG)K4+]L8+)=R*"G(J$''"O_5N]N952=%)<N%:WV'AT%=
M.;;VZ'FX]/AUQ5AP^H_:2A4ZQA$))E$<F.YC='UJ6FF!QQBSDD/V\.[)O?]!
MW0XQS, *EK-.C'KGP@\1 DUL8C9VWE5KAGN>"MV35_A'6-02]"Y.5H>/NS(>
M4^>M<*(.N)B'AT&A[7@B+%^38XTB>>==,/N%.'LB_HO;40C1D%G2$"79*7X2
M4718$D>Y/T8)TC6Z0!'!GRJ8WAQKFFR&%AU/QNC!\ Q?G^8A@[9ZJ7?P4\O%
M'L^TQ)\V3429)T6!+J6@:5D@;6VZWZ,LFLD_,/6IZZ.>$/_X4A=B3JVT)E4J
M8Y"-EG(,*@X+1^<K(MQ $Y_2BJ7K1^NJ*%O7@Y07H2Z8W,@U2XR""\Z1\G4/
M 1,^%YP0$S[N4]4I#,[Q93B)I&^S]>4J*YW0T74GLR.I' N"[TTR$KQ"ZG)<
MD$0\.1-;&I$],8_M9>F]_17ZRL0N.?V,5"C*\9YP1W/.;^SH'3D:N)5M,4_]
MNC@.O&2B+(:ZHPYW@CBKV-^A^S5!QRY] T,8;$2(<UNN-FKL]I>2#)S>MSB_
MD-_P38Y+W'$TC0KGFHKKTAJ4OD4K;+Z.:K:@<S(!]0R8![U*H%@('69??>I3
M\(X D _L;5G\[[GB?8Z1G59(U$Y[O-]]^C*M2P,1)@!Z0Q0G4N=7-N6R&F*'
M7D2X(M//OM/[; 6_/8QN4>4<6>+TUWA7)<8JRJ'M)@+@>_60C4ZC!8#.MNS,
M=PCK#&O@T,*2L6EU<NVX=F5<2<;-4:4$&0\1MY^L">6');+71\&LW+5Y%>.!
M8];RZ;)4V*?I:L?7X Q,I<4XUN&0@/!MM./-FYS1$_6CB&IN3-26"I&5<@<_
M*#64)O(FA9,W]UCMF7*]]_6E7.]]2[G^-VOQ'[@W*N81N\4=)LM\3!IXS@!5
M$_N-4*/&QT;5U"W$PIRYKT_UA.!4HJ.B3Z"2 _OGNY-[GOAIOT<90V[\M/NC
MM&FJ FKB'N+@@.-]#@&[UUU-6FZ%]]'X/6S*TWT0(%LD.$UETJ[%LT**!]NS
MN73Y,5?U%.;'1C2[/(VQQ?G#;3%3B&+RSQRS@IOK17$E$GT*LDM]<;428"X?
M41=6$U1Y=@FO A]L&U(IL^4"^A,$,F262F<@W7$YI]%(%PUAH=,B.:HGDDV>
M0-$Y3G.FRY((QR#!/(TA^DP=E^S[5E"875Q+H90RH#.8"3O&2RI$*L8T.N'K
M/JA=#H$\I2<;6MKQ\H7+TH_732GC%4_U484#09NB]%H?*3'!J.6#3$ECMMRN
MV!SAPO=BP7[,UW97\MVL7'NEH%DM=U\R!:]28L:ALGK3PTNY<IDBDP/C]T -
ME5B'6G,W(%B4'A2)5$N2KA28KVYWL%\"BJ_ _+ILYT04UV]FJ\JGP=VKX?AT
M5;^HYE9^IT:1R2"D-<]X%'GVN&5:,_CEKT5S@4'5QJFZ8D'TUD&E+L8$-@*M
M$+!)%R5D\4\D_6WGVT@/UF ,)$9FWU)P:[[I>\\M;<J54U9K0/X=H":34B9M
MN,:K+3$AX2*4TR/U(XBM[UR5[*FCL?:GB?O^4F./3"NCY,[@SE<4+.G##F_Q
M-FJ$AJ *W6";VJ3>23?@"H,SL@'2Q<AYS%ART0@H17##^MWK1(_7 IP,&;Q/
M%RP5&9"I%E2HAOZ>"6N$UM?V\4A.8K;57 :%Z-9;E]C%] _H0:S<HW00!@.0
MUXA8:2C]@ZZ?2VRXS#^U<\M*=(ZTBY'\Z=BE=45'#B+BG*-PI6NT8IJHH-(_
MX\T%Y8]1@9UT<>"E<@S&&J8X;Q6'ZREU)]95@52JV%^V<8D@GPX#>8]#&Z:F
M.^!*85)@?5EE23\E@.A-(-@<:GD<8'QU7JP24>9.Y4B'.VO:*@2V4<I_C+LJ
MY#'=2PQ1B\Q/WIX1:S[GS.!2NQ014ZS.#H$T-03"IN_0+=2).7[8TMU'DRW?
M!&CC02WCSG,>5F1LAJ#W@<$094(WVYLBY\D)W1:CD F1WV[@O(!MYR*'UWH7
M$\T*>GI0:9-#+N1J041#4 !U:Q;SGI0YL0!Y7*K5;I)'E(I^KFFZ:IF^H^,F
M-6@R%H2:DP 8Y_FN_O_VKJVW:6T)OR/Q'ZQ*2%0*I2WT[",VNSI.XK;9.R11
MXNZ"CLZ#FSC4(K&]'8<J__ZLN:V+[4 1+93""Z2YK+6\+C-K9K[Y1BAP4X,R
MLBY31-B!8;U83SJ2>5C$@#8^8PJD9P:2@<W;W5OX&PI6:MH,%O1X?17H&=-Q
MV+!,)#@FQ<5 (9#5Q#YG6Y)IS(4]V"^I.4CT6+!T#5Y,/L9V>7@3O[9!#CC.
M9ZC,'.2:N,SV\MF<?65*B&!"%D  (JS'S@GQIF66S,#] 08^FD#X[.*]-1+4
M-I$W0I>@OH')4%@N=14+ 83;"]+QR9[8->(*)T+$_4R3.JXTZ*/^2)6@/A/F
M074IJ(HDB5[EP_+!$W//! D<B(28C5M6L@ \;KG!1$X1Q5@BY94W!_X3<'4L
M&%M))4G17ESF,58J<RZ<Y ]62@9VB=K_"[00E<J$^H_(#)BR^C8D\07 ;E*.
M594F.\SH=IME@KCG](!M4(<CBJE5$"_S]6)!>XC.OV8&%5&0 ,9<>&HD:-?B
MD">!&OB)(LT77_<$N?7'$T(A0:2483-:D=L\]_,D95N?:J4!^F&!5CW*).+W
M!&-A>I7$K%CP3.#M^Q*@AR5UH#_ABJT1WQZK-K3&H=O; 8R#QOV@! _O ,JN
M+I-\34V1] -"(QT-%X,_K<H"S22JWE"7QVRMMA,*5ZT%S#X@4-(7[0#Q;[@4
M5')]X=1D7%QX#(*3Z:'7]JK7N%4?C*!XP956IHP)@-F$?-E9$5U'B\>/QG"E
M%Y*O+9PB%0B]RS'RU$H/,1FXI*VH0)-S:=^UK>N:)\<* 2$?9AI+M543V3*I
MK!$9)"TB&&<L_!)OR$JXY(;/D]!X]<*EU7HQLXSL=;4CF3&=T/1\-Z>38%L0
M5M%O260M62S9%<#BM!J>@PU:P*K08*]Y1=!D@<Y64%T;W!A*U."\( >'%&'$
M_S&*VIPT8[-/('7#1SCJ]!U[CF3>B$0X(V)?&#M$PF5-U<48O3<Q\J#!X!CJ
M(FPC>$ Q7EE/D/$:\V-JV*C";%#B[W- )PVYRF@G\FM2*XVE(6NYW%0#2 V?
M70K-++Z6C\4@7FBUXEDU'P&]4&XQ$99OV$TMY4HV?_3^/7AH2PMA0P2N0H=G
M[TSM?EFY!2H*K#8=L>F\E2U"&^[1E' M=ELU3MCZ[QOJ8)CY=])$'(IC6-A<
M!X_8GA('S!0?G3PLNFX\/4_,&^H^)S?=,+A[^/,%=P]_!7>_M]9_25K?G#T'
M%N;:"O9QU"0=^"/K<%;2H-05<:ELO05=D!?9"@I?ETJ!I)1DH9K(-JS[*OEF
M1&8-?EBLO0,ZY3(6IFGPG@J9.3DY+\GQ"9J!\B*)P)V9I1=DAXJW]VE%L? 8
M@72#^>G5#25>>SKCQVH=VP B>T"\IFI-MLX+48!C:BP.15#N@ 02A[%5JF>E
M!K":1U.LKU(1ZR*QJ9:\^F1>Z@FD("2'X%F[2;W=3P^0+SU4#S8IU&4'[G3@
MA[8@M;GX=(VE@L'\9V3-DW?12':EY=2>4]NTV)AZGKL0U<BFQ#=J?(Y5YGA;
M"3Q -]@1';9E/).S95<>YDI1<(ALLG.#Q07CE=!>3M81$K]H]E=RHMO,EY"8
M(:X>IBSGW-8Z% +IT.Q])UXY:T"-M!>F2-,6EMO01NJ!#X'MKRR-2]@J/#+L
MD."3ZGC-E$J@"M5+<%Q'UNG>X%%P\F-I@TILBY.BU5_V/;S">K@M$F]%[7"P
MN#;$HR(4F-LB=7@!V\(,HN^(EFN,7, 4[";_G9#10]9"=,UF,7@@>#H>S'E
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MY'!/2M^;O;[WVQ$3<K]5CZ 4GE(6$]$A@P[J \\YV[A3B/U!W29?>>L\5T9
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M%2&DRR<$:W%:6HL<UFM+?Z28 JGHF>&@(S?#LG&=$MA<,F?.#A4DOQ8HJ2/
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MQO^M'"Q?-2Q+,\P!A:3-<?]J 1]FH@LR=6..@C.F$M."H!?,9I:P-!8BH%(
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MI-P!SO!Y0 B(7'P@_(O1(SM7M"F"2U;)PC)TK)X]+:FXP+?<^!SXW#*8Z;Z
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MN31/Q152<&4"F:5QI,I1=;J0(PMM-*\5P+P$7!IDWKY6]DQ!M=56T-0$8$\
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MA]OA+YYNQ\>')^_./HJKZX^3\W\^FMJBVA?CG;(2USI77KQ5"W%I<UD,PL!
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M^X?DDL:#$*EU?@#1;-KQJ$0!PM%VUH>&4/L$XRK)(IR67J[$MJRC>1:M:T!
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M,5\X:RYH=&U02P$"% ,4    " #6@ =;*&)<X-LH  !8[@  %0
M    @ 'H&@  =&TR-3(R-C4T9#%?97@Q+3$N:'1M4$L! A0#%     @ UH '
M6P9:8KD:A@  HIP" !8              ( !]D,  '1M,C4R,C8U-&0Q7V5X
M,3 M,2YH=&U02P$"% ,4    " #6@ =;J4Y5%^H0  "8;   %@
M    @ %$R@  =&TR-3(R-C4T9#%?97@Q,"TR+FAT;5!+ 0(4 Q0    ( -:
M!UL7"1/N\Q   (IM   6              "  6+;  !T;3(U,C(V-31D,5]E
M>#$P+3,N:'1M4$L! A0#%     @ UH '6W<OI!3V10  ,ID! !4
M     ( !B>P  '1M,C4R,C8U-&0Q7V5X-"TQ+FAT;5!+ 0(4 Q0    ( -:
M!UN06TMZ9PT  )0F   6              "  ;(R 0!T;3(U,C(V-31D,5]E
M>#DY+3$N:'1M4$L! A0#%     @ UH '6WWC3'8H P  Z L  !$
M     ( !34 ! 'AE;&(M,C R-3 X,#$N>'-D4$L! A0#%     @ UH '6_#T
MV5;]"@  ?X8  !4              ( !I$,! 'AE;&(M,C R-3 X,#%?;&%B
M+GAM;%!+ 0(4 Q0    ( -: !UOPX>L*6@<  -A7   5              "
M =1. 0!X96QB+3(P,C4P.# Q7W!R92YX;6Q02P4&      H "@"; @  858!
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>tm2522654d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="xelb-20250801.xsd" xlink:type="simple"/>
    <context id="AsOf2025-08-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083220</identifier>
        </entity>
        <period>
            <startDate>2025-08-01</startDate>
            <endDate>2025-08-01</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-08-01" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-08-01" id="Fact000004">0001083220</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-08-01" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-08-01" id="Fact000010">2025-08-01</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-08-01" id="Fact000011">XCEL BRANDS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-08-01" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-08-01" id="Fact000013">001-37527</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-08-01" id="Fact000014">76-0307819</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-08-01" id="Fact000015">550 Seventh Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-08-01" id="Fact000016">11th Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-08-01" id="Fact000017">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-08-01" id="Fact000018">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-08-01" id="Fact000019">10018</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-08-01" id="Fact000020">347</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-08-01" id="Fact000021">727-2474</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-08-01" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-08-01" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-08-01" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-08-01" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-08-01" id="Fact000026">false</dei:EntityEmergingGrowthCompany>
    <dei:Security12bTitle contextRef="AsOf2025-08-01" id="Fact000027">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-08-01" id="Fact000028">XELB</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-08-01" id="Fact000029">NASDAQ</dei:SecurityExchangeName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
